Guillain-Barré syndrome

Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 100 000 people developing the disorder every year worldwide. Under the umbrella term of Guillain-Barré syndrome are several recognisable variants with distinct clinical and pathological features. The se...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 388; no. 10045; pp. 717 - 727
Main Authors:	Willison, Hugh J, Jacobs, Bart C, van Doorn, Pieter A
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 13.08.2016 Elsevier Limited
Subjects:	Axons - immunology Axons - pathology Biomarkers Campylobacter Infections - complications Campylobacter Infections - immunology Campylobacter jejuni Clinical Trials as Topic Diagnosis, Differential Disease Management Electrophysiology Epidemiology Guillain-Barre syndrome Guillain-Barre Syndrome - complications Guillain-Barre Syndrome - diagnosis Guillain-Barre Syndrome - epidemiology Guillain-Barre Syndrome - immunology Guillain-Barre Syndrome - physiopathology Guillain-Barre Syndrome - therapy Humans Immunoglobulins, Intravenous - therapeutic use Infections Influenza Vaccines - administration & dosage Influenza Vaccines - adverse effects Internal Medicine Medical prognosis Muscle Weakness - complications Muscle Weakness - etiology Neural Conduction - immunology Neuropathology Paralysis - complications Paralysis - immunology Plasma Exchange Plasmapheresis Prognosis Respiratory Insufficiency - etiology Respiratory Insufficiency - prevention & control Treatment Outcome Vaccines
ISSN:	0140-6736, 1474-547X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 100 000 people developing the disorder every year worldwide. Under the umbrella term of Guillain-Barré syndrome are several recognisable variants with distinct clinical and pathological features. The severe, generalised manifestation of Guillain-Barré syndrome with respiratory failure affects 20–30% of cases. Treatment with intravenous immunoglobulin or plasma exchange is the optimal management approach, alongside supportive care. Understanding of the infectious triggers and immunological and pathological mechanisms has advanced substantially in the past 10 years, and is guiding clinical trials investigating new treatments. Investigators of large, worldwide, collaborative studies of the spectrum of Guillain-Barré syndrome are accruing data for clinical and biological databases to inform the development of outcome predictors and disease biomarkers. Such studies are transforming the clinical and scientific landscape of acute autoimmune neuropathies.
AbstractList	Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 100 000 people developing the disorder every year worldwide. Under the umbrella term of Guillain-Barré syndrome are several recognisable variants with distinct clinical and pathological features. The severe, generalised manifestation of Guillain-Barré syndrome with respiratory failure affects 20–30% of cases. Treatment with intravenous immunoglobulin or plasma exchange is the optimal management approach, alongside supportive care. Understanding of the infectious triggers and immunological and pathological mechanisms has advanced substantially in the past 10 years, and is guiding clinical trials investigating new treatments. Investigators of large, worldwide, collaborative studies of the spectrum of Guillain-Barré syndrome are accruing data for clinical and biological databases to inform the development of outcome predictors and disease biomarkers. Such studies are transforming the clinical and scientific landscape of acute autoimmune neuropathies. Summary Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 100 000 people developing the disorder every year worldwide. Under the umbrella term of Guillain-Barré syndrome are several recognisable variants with distinct clinical and pathological features. The severe, generalised manifestation of Guillain-Barré syndrome with respiratory failure affects 20–30% of cases. Treatment with intravenous immunoglobulin or plasma exchange is the optimal management approach, alongside supportive care. Understanding of the infectious triggers and immunological and pathological mechanisms has advanced substantially in the past 10 years, and is guiding clinical trials investigating new treatments. Investigators of large, worldwide, collaborative studies of the spectrum of Guillain-Barré syndrome are accruing data for clinical and biological databases to inform the development of outcome predictors and disease biomarkers. Such studies are transforming the clinical and scientific landscape of acute autoimmune neuropathies. Guillain-Barre syndrome is the most common and most severe acute paralytic neuropathy, with about 100000 people developing the disorder every year worldwide. Under the umbrella term of Guillain-Barre syndrome are several recognisable variants with distinct clinical and pathological features. The severe, generalised manifestation of Guillain-Barre syndrome with respiratory failure affects 20-30% of cases. Treatment with intravenous immunoglobulin or plasma exchange is the optimal management approach, alongside supportive care. Understanding of the infectious triggers and immunological and pathological mechanisms has advanced substantially in the past 10 years, and is guiding clinical trials investigating new treatments. Investigators of large, worldwide, collaborative studies of the spectrum of Guillain-Barre syndrome are accruing data for clinical and biological databases to inform the development of outcome predictors and disease biomarkers. Such studies are transforming the clinical and scientific landscape of acute autoimmune neuropathies.
Author	Jacobs, Bart C van Doorn, Pieter A Willison, Hugh J
Author_xml	– sequence: 1 givenname: Hugh J surname: Willison fullname: Willison, Hugh J email: Hugh.Willison@glasgow.ac.uk organization: Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK – sequence: 2 givenname: Bart C surname: Jacobs fullname: Jacobs, Bart C organization: Department of Neurology, Erasmus MC, University Medical Center, Rotterdam, Netherlands – sequence: 3 givenname: Pieter A surname: van Doorn fullname: van Doorn, Pieter A organization: Department of Neurology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/26948435$$D View this record in MEDLINE/PubMed
BookMark	eNqNkd9KHDEUh4Ns0XXtfW9aCr2xF6P5vxnEipV2FRa8aAXvQiZzBrKdzWgyI-wj-Ry-mJkdu4WFohASDnznS_I7-2jkGw8IfST4iGAij39hwnEmp0weEvkVY8byjOygMeFTngk-vR2h8QbZQ_sxLjDGXGKxi_aozLniTIzRh1nn6to4n303ITw9fo4rX4ZmCQfoXWXqCO9fzgm6-fnj98VlNr-eXV2czzMrFG0zwwpFgBhFCkqNIIIzmXZcAVOMlZSDslLSPNW44mWuMOXWyqqAgpdggU3Q4eC9C819B7HVSxctpDd5aLqoiSJC5oSl9QaUKjVltEe_bKGLpgs-faSnOKWMUpGoTy9UVyyh1HfBLU1Y6b_xJEAMgA1NjAGqDUKw7seg12PQfcY6Vesx6P76k60-61rTusa3wbj61e6zoRtS7g8Ogo7WgbdQugC21WXjXjV82zLY2nlnTf0HVhD_ZaEj1XiQ9A4i14ZecPp_wRse8Az6BcVP
CODEN	LANCAO
CitedBy_id	crossref_primary_10_1007_s00234_025_03728_5 crossref_primary_10_1186_s12883_022_02599_0 crossref_primary_10_1080_21645515_2021_1985890 crossref_primary_10_3389_fneur_2022_955933 crossref_primary_10_7759_cureus_13096 crossref_primary_10_1038_s41409_022_01690_x crossref_primary_10_1212_CPJ_0000000000000793 crossref_primary_10_1007_s11908_017_0590_9 crossref_primary_10_1002_rmv_1978 crossref_primary_10_3389_fneur_2024_1385945 crossref_primary_10_1097_CAD_0000000000000739 crossref_primary_10_1186_s12887_024_05298_6 crossref_primary_10_1021_jacs_0c08583 crossref_primary_10_18276_cej_2025_1_04 crossref_primary_10_1016_j_clim_2019_07_007 crossref_primary_10_1002_chem_201804862 crossref_primary_10_1177_17562864231154306 crossref_primary_10_1016_j_medcle_2019_02_043 crossref_primary_10_1002_ijgo_12018 crossref_primary_10_3389_fmed_2022_991182 crossref_primary_10_1007_s00415_024_12317_0 crossref_primary_10_7759_cureus_26158 crossref_primary_10_1016_j_heliyon_2023_e14321 crossref_primary_10_1155_2019_1902732 crossref_primary_10_1002_prp2_1224 crossref_primary_10_1111_ene_14748 crossref_primary_10_1038_pr_2017_67 crossref_primary_10_3390_neurolint13030040 crossref_primary_10_1016_j_medcli_2025_107014 crossref_primary_10_1007_s13760_021_01603_7 crossref_primary_10_4103_ANT_33_4_112_0089 crossref_primary_10_1089_fpd_2019_2664 crossref_primary_10_1007_s13691_018_0326_1 crossref_primary_10_7759_cureus_45940 crossref_primary_10_12998_wjcc_v9_i5_1096 crossref_primary_10_1097_WCO_0000000000000602 crossref_primary_10_3389_fendo_2022_914325 crossref_primary_10_3390_vaccines10030408 crossref_primary_10_1002_mus_26056 crossref_primary_10_1136_pn_2023_003966 crossref_primary_10_3390_microorganisms10112139 crossref_primary_10_1136_bcr_2020_237215 crossref_primary_10_1111_jns_12382 crossref_primary_10_1089_vim_2021_0187 crossref_primary_10_1038_s41390_021_01919_3 crossref_primary_10_1007_s00401_016_1599_0 crossref_primary_10_1002_ccr3_2613 crossref_primary_10_3389_fsurg_2022_903334 crossref_primary_10_1016_j_medcle_2025_107014 crossref_primary_10_1002_mus_27374 crossref_primary_10_1016_j_revmed_2021_12_005 crossref_primary_10_1038_s41598_018_35820_7 crossref_primary_10_1128_spectrum_00690_22 crossref_primary_10_1186_s13613_025_01464_w crossref_primary_10_1016_j_jneuroim_2019_577048 crossref_primary_10_1186_s12883_023_03143_4 crossref_primary_10_3390_cells10082134 crossref_primary_10_1097_MD_0000000000020227 crossref_primary_10_1097_JXX_0000000000000400 crossref_primary_10_1111_jns_70022 crossref_primary_10_1128_cmr_00074_24 crossref_primary_10_26508_lsa_202101168 crossref_primary_10_1002_jmv_24620 crossref_primary_10_2478_jccm_2021_0030 crossref_primary_10_1016_j_medcli_2019_02_005 crossref_primary_10_1177_2050313X211042215 crossref_primary_10_1016_j_intimp_2023_111368 crossref_primary_10_3390_medicina57080775 crossref_primary_10_1093_glycob_cwz082 crossref_primary_10_59556_japi_73_0963 crossref_primary_10_3390_cells10092191 crossref_primary_10_1038_s41598_023_32427_5 crossref_primary_10_1007_s11940_023_00756_5 crossref_primary_10_1038_cmi_2017_142 crossref_primary_10_1038_s41598_020_71967_y crossref_primary_10_1016_j_neuarg_2025_06_006 crossref_primary_10_1186_s41983_023_00764_x crossref_primary_10_1038_s41572_018_0027_2 crossref_primary_10_1038_s41598_019_46389_0 crossref_primary_10_1097_PHM_0000000000002179 crossref_primary_10_1002_brb3_1496 crossref_primary_10_3389_fimmu_2021_674922 crossref_primary_10_1016_j_neurol_2019_07_004 crossref_primary_10_1001_jamanetworkopen_2022_53845 crossref_primary_10_1186_s12883_017_0982_3 crossref_primary_10_1212_WNL_0000000000007719 crossref_primary_10_1016_j_ncl_2018_06_003 crossref_primary_10_7759_cureus_18325 crossref_primary_10_1097_CND_0000000000000193 crossref_primary_10_1016_j_mcna_2024_09_007 crossref_primary_10_1002_pds_4807 crossref_primary_10_1111_jns_12189 crossref_primary_10_1002_mus_27172 crossref_primary_10_1111_jns_70009 crossref_primary_10_1016_j_jns_2021_120057 crossref_primary_10_1007_s00415_020_10219_5 crossref_primary_10_31083_j_jin2103077 crossref_primary_10_1515_jpm_2023_0310 crossref_primary_10_3389_fimmu_2022_946825 crossref_primary_10_1093_ptj_pzac049 crossref_primary_10_1177_19714009221096823 crossref_primary_10_3389_fneur_2021_635753 crossref_primary_10_3389_fimmu_2022_872683 crossref_primary_10_7759_cureus_50259 crossref_primary_10_36303_JMLSTSA_2020_2_2_48 crossref_primary_10_1016_j_autrev_2020_102665 crossref_primary_10_1002_mus_27179 crossref_primary_10_2106_JBJS_CC_19_00530 crossref_primary_10_1016_j_jcrc_2018_01_016 crossref_primary_10_1371_journal_pone_0239099 crossref_primary_10_1111_acem_14861 crossref_primary_10_1155_2021_6627779 crossref_primary_10_1111_hex_13116 crossref_primary_10_1111_jns_12571 crossref_primary_10_1055_s_0041_1726358 crossref_primary_10_1111_ene_16073 crossref_primary_10_1093_infdis_jiae411 crossref_primary_10_1136_bcr_2020_238116 crossref_primary_10_5812_ijp_128852 crossref_primary_10_1002_jmv_27018 crossref_primary_10_1007_s10072_021_05108_2 crossref_primary_10_1111_hex_13367 crossref_primary_10_3389_fneur_2024_1362648 crossref_primary_10_1016_j_jns_2020_116908 crossref_primary_10_1097_NRL_0000000000000230 crossref_primary_10_1080_1744666X_2021_2002147 crossref_primary_10_1007_s40262_022_01136_z crossref_primary_10_1016_j_actatropica_2022_106366 crossref_primary_10_1097_WNO_0000000000001176 crossref_primary_10_1186_s13054_020_03121_z crossref_primary_10_1007_s00415_020_10261_3 crossref_primary_10_1007_s00415_020_09849_6 crossref_primary_10_2147_JIR_S505159 crossref_primary_10_1136_bcr_2020_236182 crossref_primary_10_1016_j_rmed_2025_107951 crossref_primary_10_1002_ccr3_5733 crossref_primary_10_7759_cureus_74657 crossref_primary_10_1016_j_yapd_2023_04_001 crossref_primary_10_1172_JCI158524 crossref_primary_10_1111_ene_16090 crossref_primary_10_1016_j_ijfoodmicro_2024_111029 crossref_primary_10_1177_03000605241306655 crossref_primary_10_4037_ccn2021129 crossref_primary_10_1186_s12974_019_1566_5 crossref_primary_10_1016_j_jiac_2017_04_014 crossref_primary_10_1177_2058739220942340 crossref_primary_10_4274_tnd_2021_86094 crossref_primary_10_1053_j_sult_2016_05_006 crossref_primary_10_1002_acn3_51939 crossref_primary_10_1097_MD_0000000000040700 crossref_primary_10_7759_cureus_21085 crossref_primary_10_3390_neurolint13020019 crossref_primary_10_1002_eji_202250336 crossref_primary_10_3390_vaccines8010101 crossref_primary_10_4103_ara_ara_7_23 crossref_primary_10_3390_v13091771 crossref_primary_10_3389_fneur_2023_1108738 crossref_primary_10_1007_s00415_021_10515_8 crossref_primary_10_1111_ene_16030 crossref_primary_10_3389_fneur_2019_00714 crossref_primary_10_1007_s11940_019_0569_y crossref_primary_10_1016_j_nmd_2021_05_012 crossref_primary_10_1177_0300985820934112 crossref_primary_10_1097_AOG_0000000000001716 crossref_primary_10_1002_jca_21705 crossref_primary_10_1186_s41983_023_00646_2 crossref_primary_10_1002_mus_26905 crossref_primary_10_1016_j_ebiom_2024_105072 crossref_primary_10_1212_CON_0000000000000513 crossref_primary_10_4103_injms_injms_126_20 crossref_primary_10_1111_jns_12597 crossref_primary_10_1111_jns_12358 crossref_primary_10_1177_0883073817748109 crossref_primary_10_1016_j_braindev_2021_02_003 crossref_primary_10_3389_fimmu_2025_1610219 crossref_primary_10_1007_s10072_021_05087_4 crossref_primary_10_21615_cesmedicina_34_2_8 crossref_primary_10_1016_j_biopha_2021_111489 crossref_primary_10_1111_jns_12594 crossref_primary_10_3390_cells11182897 crossref_primary_10_1099_ijsem_0_006635 crossref_primary_10_1007_s00415_020_10034_y crossref_primary_10_1136_rapm_2020_101792 crossref_primary_10_1016_S0140_6736_17_30055_7 crossref_primary_10_1007_s10072_021_05733_x crossref_primary_10_1002_1873_3468_13980 crossref_primary_10_1016_j_tmrv_2022_05_002 crossref_primary_10_1080_01616412_2025_2476514 crossref_primary_10_1212_NXI_0000000000200405 crossref_primary_10_1016_j_bbmt_2019_04_021 crossref_primary_10_1371_journal_pone_0187830 crossref_primary_10_1016_j_vaccine_2019_05_041 crossref_primary_10_1016_j_jaut_2016_12_007 crossref_primary_10_1097_INF_0000000000003550 crossref_primary_10_1097_IPC_0000000000000901 crossref_primary_10_1186_s40814_017_0185_0 crossref_primary_10_1007_s12028_019_00846_w crossref_primary_10_1177_0883073821989164 crossref_primary_10_1002_ccr3_70932 crossref_primary_10_1177_08903344221079645 crossref_primary_10_36290_neu_2021_005 crossref_primary_10_2147_JIR_S507515 crossref_primary_10_1016_j_jns_2017_04_006 crossref_primary_10_1111_cen3_12343 crossref_primary_10_1016_j_medin_2016_10_005 crossref_primary_10_3390_pathogens10080936 crossref_primary_10_1159_000509681 crossref_primary_10_1136_jnnp_2016_314862 crossref_primary_10_1016_j_neulet_2021_136040 crossref_primary_10_1111_ene_16346 crossref_primary_10_1097_MS9_0000000000003583 crossref_primary_10_1080_14737175_2023_2273386 crossref_primary_10_1097_CND_0000000000000214 crossref_primary_10_1111_ene_15011 crossref_primary_10_1098_rsos_220491 crossref_primary_10_3389_fped_2022_815976 crossref_primary_10_3390_vaccines10122174 crossref_primary_10_1016_S0140_6736_17_30047_8 crossref_primary_10_7759_cureus_70787 crossref_primary_10_1136_jnnp_2020_324837 crossref_primary_10_1016_S1474_4422_20_30494_4 crossref_primary_10_1007_s12035_017_0635_y crossref_primary_10_1097_PCC_0000000000002930 crossref_primary_10_1111_ene_16365 crossref_primary_10_1080_21645515_2022_2045153 crossref_primary_10_3389_fneur_2018_01139 crossref_primary_10_1093_qjmed_hcab157 crossref_primary_10_1177_2324709620961198 crossref_primary_10_1007_s10072_023_06784_y crossref_primary_10_3389_fneur_2021_730129 crossref_primary_10_7759_cureus_49745 crossref_primary_10_1016_S0140_6736_20_32723_9 crossref_primary_10_1177_1091581817740873 crossref_primary_10_1111_jfs_12819 crossref_primary_10_1016_j_jchemneu_2022_102101 crossref_primary_10_1186_s13256_021_02988_y crossref_primary_10_1016_j_ncl_2021_11_013 crossref_primary_10_1007_s00112_023_01756_0 crossref_primary_10_1186_s12879_019_4278_7 crossref_primary_10_1017_cjn_2017_205 crossref_primary_10_1016_j_braindev_2022_07_003 crossref_primary_10_1002_jgf2_481 crossref_primary_10_1016_j_jns_2019_10_991 crossref_primary_10_3389_fnins_2018_00467 crossref_primary_10_1038_s41582_019_0250_9 crossref_primary_10_1007_s12028_023_01707_3 crossref_primary_10_1016_j_clineuro_2025_108719 crossref_primary_10_1111_jns_12531 crossref_primary_10_1016_S1474_4422_20_30221_0 crossref_primary_10_1136_bcr_2017_222995 crossref_primary_10_1111_ene_15213 crossref_primary_10_3390_v10040198 crossref_primary_10_1007_s00415_016_8380_0 crossref_primary_10_1016_j_medine_2016_10_005 crossref_primary_10_1016_j_legalmed_2025_102646 crossref_primary_10_1016_j_pulmoe_2018_10_008 crossref_primary_10_4103_aian_AIAN_1303_20 crossref_primary_10_3389_fimmu_2023_1301577 crossref_primary_10_1111_jnc_15459 crossref_primary_10_1088_1361_6579_ab85cf crossref_primary_10_12998_wjcc_v10_i6_1896 crossref_primary_10_1111_jns_12520 crossref_primary_10_2147_IMCRJ_S483673 crossref_primary_10_3389_fmicb_2016_01398 crossref_primary_10_1016_j_clineuro_2020_106250 crossref_primary_10_1186_s40168_017_0284_4 crossref_primary_10_1002_wmh3_474 crossref_primary_10_1186_s13578_023_00956_1 crossref_primary_10_1016_j_ejpn_2016_08_001 crossref_primary_10_1016_j_jneuroim_2017_05_008 crossref_primary_10_1080_01616412_2025_2511097 crossref_primary_10_1016_j_wneu_2021_02_140 crossref_primary_10_1080_14728222_2017_1258402 crossref_primary_10_1002_acn3_556 crossref_primary_10_1016_j_heliyon_2022_e11354 crossref_primary_10_1186_s12883_018_1211_4 crossref_primary_10_1002_brb3_70566 crossref_primary_10_7759_cureus_44008 crossref_primary_10_1177_11795549211056261 crossref_primary_10_1007_s10072_019_04156_z crossref_primary_10_1177_10497323241304641 crossref_primary_10_26815_acn_2019_00143 crossref_primary_10_7759_cureus_45101 crossref_primary_10_12890_2021_002211 crossref_primary_10_1002_mus_27506 crossref_primary_10_1016_j_cllc_2019_11_001 crossref_primary_10_1097_MD_0000000000038304 crossref_primary_10_3390_biology12050735 crossref_primary_10_1099_mic_0_001560 crossref_primary_10_4103_aian_AIAN_133_21 crossref_primary_10_3390_medicina59071267 crossref_primary_10_1111_jns_12503 crossref_primary_10_1186_s12879_018_3049_1 crossref_primary_10_1371_journal_pntd_0008032 crossref_primary_10_18214_jend_2021_00087 crossref_primary_10_3390_vaccines9091022 crossref_primary_10_1111_ene_14398 crossref_primary_10_1016_j_clineuro_2020_106037 crossref_primary_10_1016_j_autrev_2021_103019 crossref_primary_10_1002_ccr3_6451 crossref_primary_10_1007_s40495_023_00334_y crossref_primary_10_1186_s12883_025_04233_1 crossref_primary_10_3389_fneur_2019_00087 crossref_primary_10_1007_s12026_022_09316_6 crossref_primary_10_3390_v16111704 crossref_primary_10_1016_j_cej_2025_167697 crossref_primary_10_1097_MS9_0000000000000236 crossref_primary_10_1016_j_nrleng_2023_12_004 crossref_primary_10_1038_s41598_020_60267_0 crossref_primary_10_1007_s10867_025_09689_3 crossref_primary_10_1097_PCC_0000000000002075 crossref_primary_10_1093_jac_dkz573 crossref_primary_10_1111_jfs_12442 crossref_primary_10_1186_s12879_020_05506_5 crossref_primary_10_1038_s41582_020_0398_3 crossref_primary_10_1080_10833196_2021_1908729 crossref_primary_10_1136_bcr_2021_246701 crossref_primary_10_1016_j_vaccine_2019_08_045 crossref_primary_10_1016_S1474_4422_18_30144_3 crossref_primary_10_1136_bmjno_2019_000020 crossref_primary_10_1007_s00256_023_04428_y crossref_primary_10_7759_cureus_82954 crossref_primary_10_1097_MD_0000000000033754 crossref_primary_10_1111_neup_13006 crossref_primary_10_1016_j_micinf_2022_104954 crossref_primary_10_1186_s12967_020_02615_2 crossref_primary_10_1038_s41582_021_00467_y crossref_primary_10_1007_s15202_017_1500_6 crossref_primary_10_1186_s40893_017_0021_7 crossref_primary_10_1002_bies_201800239 crossref_primary_10_1007_s00415_021_10773_6 crossref_primary_10_1016_j_jocn_2020_01_067 crossref_primary_10_1007_s11481_020_09924_9 crossref_primary_10_7759_cureus_40083 crossref_primary_10_1016_j_bbih_2022_100578 crossref_primary_10_7759_cureus_78460 crossref_primary_10_1007_s00415_025_13238_2 crossref_primary_10_1186_s12879_021_07025_3 crossref_primary_10_1016_j_ncl_2020_03_008 crossref_primary_10_1159_000505964 crossref_primary_10_1186_s12985_024_02547_z crossref_primary_10_1016_j_jaut_2018_10_006 crossref_primary_10_3389_fneur_2018_00206 crossref_primary_10_1016_S1473_3099_17_30446_2 crossref_primary_10_1038_s41598_022_09621_y crossref_primary_10_1002_ccr3_8204 crossref_primary_10_1016_j_emc_2020_02_006 crossref_primary_10_1016_j_braindev_2022_09_007 crossref_primary_10_4103_0028_3886_310063 crossref_primary_10_1007_s13365_018_0656_y crossref_primary_10_1186_s12883_021_02334_1 crossref_primary_10_3389_fneur_2016_00233 crossref_primary_10_1111_ejn_15266 crossref_primary_10_1177_19418744211002676 crossref_primary_10_32604_biocell_2021_016250 crossref_primary_10_1016_j_pharmthera_2018_08_016 crossref_primary_10_1002_ijgo_13050 crossref_primary_10_1007_s11033_025_10629_6 crossref_primary_10_1096_fj_201601147R crossref_primary_10_1016_j_expneurol_2022_114127 crossref_primary_10_1016_j_micinf_2024_105342 crossref_primary_10_4274_haseki_galenos_2023_8938 crossref_primary_10_1080_01616412_2022_2056342 crossref_primary_10_1093_cid_ciz997 crossref_primary_10_1155_2023_3286330 crossref_primary_10_3389_fneur_2018_00227 crossref_primary_10_1016_j_ajem_2020_07_074 crossref_primary_10_7759_cureus_10208 crossref_primary_10_3389_fneur_2024_1484661 crossref_primary_10_1016_j_pediatrneurol_2021_10_003 crossref_primary_10_1016_j_mpsur_2022_10_004 crossref_primary_10_1016_j_semarthrit_2025_152805 crossref_primary_10_18214_jend_2020_00129_1 crossref_primary_10_1093_jtm_taaa143 crossref_primary_10_1177_1534734619896462 crossref_primary_10_4103_0028_3886_279657 crossref_primary_10_3390_ijms22115894 crossref_primary_10_1136_bcr_2019_233591 crossref_primary_10_1097_CJI_0000000000000364 crossref_primary_10_3233_PRM_180562 crossref_primary_10_1177_0883073820905157 crossref_primary_10_3390_brainsci11101354 crossref_primary_10_1016_j_ijoa_2021_103172 crossref_primary_10_15446_revfacmed_v67n2_68373 crossref_primary_10_1017_cjn_2020_106 crossref_primary_10_1002_acn3_744 crossref_primary_10_3390_microorganisms10071403 crossref_primary_10_1111_tmi_13508 crossref_primary_10_7759_cureus_18153 crossref_primary_10_1016_j_clicom_2021_12_002 crossref_primary_10_1016_j_arbres_2018_09_003 crossref_primary_10_1177_19418744221138634 crossref_primary_10_1177_08830738221089476 crossref_primary_10_1016_j_autrev_2025_103857 crossref_primary_10_1016_j_clineuro_2017_05_006 crossref_primary_10_1002_acn3_51627 crossref_primary_10_3390_immuno5030028 crossref_primary_10_1183_20734735_0218_2024 crossref_primary_10_1097_MRR_0000000000000499 crossref_primary_10_1007_s10096_018_3199_5 crossref_primary_10_1016_S0140_6736_17_30050_8 crossref_primary_10_1097_MS9_0000000000000868 crossref_primary_10_1097_MS9_0000000000000869 crossref_primary_10_3748_wjg_v23_i5_926 crossref_primary_10_5005_jp_journals_10071_24928 crossref_primary_10_1093_infdis_jix079 crossref_primary_10_3390_biomedicines12061248 crossref_primary_10_7759_cureus_38499 crossref_primary_10_1016_j_intimp_2024_113960 crossref_primary_10_1186_s12879_019_4216_8 crossref_primary_10_1111_jns_12286 crossref_primary_10_1016_j_jneuroim_2021_577719 crossref_primary_10_3389_fneur_2019_00225 crossref_primary_10_1016_j_pathol_2017_07_008 crossref_primary_10_1097_WCO_0000000000000970 crossref_primary_10_3389_fcvm_2022_1035896 crossref_primary_10_1002_ccr3_9586 crossref_primary_10_1007_s40279_021_01596_6 crossref_primary_10_1186_s12974_021_02319_4 crossref_primary_10_1136_bcr_2018_226925 crossref_primary_10_1016_j_ejpn_2017_07_005 crossref_primary_10_1016_j_ijchp_2022_100347 crossref_primary_10_3389_fneur_2020_588290 crossref_primary_10_3389_fneur_2021_678136 crossref_primary_10_1111_ene_15955 crossref_primary_10_1136_jitc_2020_001155 crossref_primary_10_1212_NXI_0000000000000952 crossref_primary_10_1016_j_autrev_2016_09_022 crossref_primary_10_3389_fped_2022_1001775 crossref_primary_10_1111_ene_14860 crossref_primary_10_1016_j_jns_2024_123050 crossref_primary_10_1515_revneuro_2023_0024 crossref_primary_10_3390_ijms22179520 crossref_primary_10_1111_cen3_12653 crossref_primary_10_7759_cureus_85240 crossref_primary_10_1002_mus_27024 crossref_primary_10_1016_j_jpeds_2025_114766 crossref_primary_10_1002_14651858_CD008630_pub5 crossref_primary_10_1111_jns_12266 crossref_primary_10_1186_s13024_023_00685_6 crossref_primary_10_3389_fneur_2025_1572949 crossref_primary_10_1016_j_chest_2023_09_009 crossref_primary_10_1016_j_jaip_2021_08_002 crossref_primary_10_1016_j_clinph_2017_03_048 crossref_primary_10_1016_j_microc_2024_111822 crossref_primary_10_4103_aian_aian_698_21 crossref_primary_10_1111_cen3_12663 crossref_primary_10_3389_fmicb_2021_665858 crossref_primary_10_3389_fnins_2022_1102119 crossref_primary_10_1016_j_jaim_2018_08_004 crossref_primary_10_1002_cns3_20022 crossref_primary_10_18203_2349_3291_ijcp20252606 crossref_primary_10_1111_dmcn_15693 crossref_primary_10_7759_cureus_61489 crossref_primary_10_1136_bcr_2016_218935 crossref_primary_10_1007_s42399_020_00646_w crossref_primary_10_1016_j_plrev_2024_01_007 crossref_primary_10_1007_s13365_021_00984_y crossref_primary_10_1080_1744666X_2021_1840355 crossref_primary_10_3389_fmicb_2021_734526 crossref_primary_10_3389_fphar_2021_799728 crossref_primary_10_1212_NXI_0000000000000721 crossref_primary_10_1097_CCM_0000000000003635 crossref_primary_10_7759_cureus_40796 crossref_primary_10_1038_s41423_020_0388_9 crossref_primary_10_1097_MRR_0000000000000469 crossref_primary_10_1016_j_bbadis_2017_02_007 crossref_primary_10_1016_S0140_6736_21_00517_1 crossref_primary_10_7759_cureus_52778 crossref_primary_10_2196_25658 crossref_primary_10_1002_acn3_51207 crossref_primary_10_4103_wjtcm_wjtcm_57_21 crossref_primary_10_1016_j_tracli_2020_12_005 crossref_primary_10_1186_s12883_017_0919_x crossref_primary_10_1017_S1466252318000014 crossref_primary_10_1097_MRR_0000000000000437 crossref_primary_10_1186_s40001_023_01055_0 crossref_primary_10_1007_s10072_021_05834_7 crossref_primary_10_1515_revneuro_2022_0006 crossref_primary_10_1007_s10072_020_04787_7 crossref_primary_10_1093_brain_aww247 crossref_primary_10_1007_s13760_020_01279_5 crossref_primary_10_1016_j_lwt_2021_111098 crossref_primary_10_1007_s12035_023_03638_8 crossref_primary_10_1007_s40261_022_01164_4 crossref_primary_10_1080_09593985_2022_2072252 crossref_primary_10_1016_j_lfs_2020_118568 crossref_primary_10_1016_j_clinph_2020_12_017 crossref_primary_10_1089_fpd_2020_2794 crossref_primary_10_1371_journal_pntd_0007622 crossref_primary_10_1111_jns_12453 crossref_primary_10_7759_cureus_85414 crossref_primary_10_1080_14712598_2018_1468885 crossref_primary_10_7759_cureus_37578 crossref_primary_10_1007_s10555_023_10108_z crossref_primary_10_1016_j_ncl_2021_01_010 crossref_primary_10_1002_glia_24000 crossref_primary_10_2169_internalmedicine_5523_25 crossref_primary_10_1111_jns_12450 crossref_primary_10_4103_2311_8571_336837 crossref_primary_10_1111_jns_12209 crossref_primary_10_1055_s_0040_1716911 crossref_primary_10_1212_WNL_0000000000200885 crossref_primary_10_1111_jns_12202 crossref_primary_10_3390_s21113716 crossref_primary_10_3390_ijms26178622 crossref_primary_10_1007_s00203_016_1268_7 crossref_primary_10_1002_acn3_50946 crossref_primary_10_1111_jns_12206 crossref_primary_10_7759_cureus_40995 crossref_primary_10_1186_s13052_025_02037_0 crossref_primary_10_12998_wjcc_v7_i18_2905 crossref_primary_10_1136_bcr_2019_230848 crossref_primary_10_1186_s12883_021_02350_1 crossref_primary_10_1016_j_lpm_2019_03_016 crossref_primary_10_1016_j_abb_2018_12_030 crossref_primary_10_1016_j_bjae_2025_05_001 crossref_primary_10_3389_fncel_2017_00414 crossref_primary_10_2147_NDT_S241128 crossref_primary_10_1002_mus_28193 crossref_primary_10_1111_jns_12434 crossref_primary_10_1016_j_msard_2025_106532 crossref_primary_10_1055_s_0043_1777767 crossref_primary_10_1016_j_cger_2021_01_005 crossref_primary_10_1186_s41983_024_00799_8 crossref_primary_10_3390_brainsci12060723 crossref_primary_10_1177_1756286420952901 crossref_primary_10_3389_fimmu_2025_1558386 crossref_primary_10_3390_microbiolres15030122 crossref_primary_10_1007_s10072_023_06802_z crossref_primary_10_1007_s10072_021_05523_5 crossref_primary_10_1016_j_mayocp_2024_03_006 crossref_primary_10_1055_a_1941_4513 crossref_primary_10_1186_s13052_025_01980_2 crossref_primary_10_1016_j_mpmed_2020_06_009 crossref_primary_10_1111_jns_12661 crossref_primary_10_1136_bcr_2021_246176 crossref_primary_10_1186_s12929_019_0562_5 crossref_primary_10_2147_PHMT_S401461 crossref_primary_10_1136_jnnp_2016_314310 crossref_primary_10_7759_cureus_53610 crossref_primary_10_1136_bcr_2024_260285 crossref_primary_10_1016_j_spen_2016_10_008 crossref_primary_10_7759_cureus_12021 crossref_primary_10_1016_j_cegh_2019_08_007 crossref_primary_10_1016_j_clineuro_2024_108131 crossref_primary_10_1080_0284186X_2020_1723163 crossref_primary_10_1371_journal_pone_0230132 crossref_primary_10_1111_jns_12419 crossref_primary_10_7759_cureus_63882 crossref_primary_10_1136_bcr_2017_219481 crossref_primary_10_7759_cureus_47174 crossref_primary_10_3166_afmu_2022_0416 crossref_primary_10_3389_fmicb_2018_01204 crossref_primary_10_1093_aje_kwx008 crossref_primary_10_3389_fnins_2020_00633 crossref_primary_10_1017_S0950268820001910 crossref_primary_10_1016_j_jns_2018_07_010 crossref_primary_10_1542_pir_2017_0061 crossref_primary_10_1007_s13365_025_01267_6 crossref_primary_10_1007_s13311_021_01117_3 crossref_primary_10_1007_s00415_020_09990_2 crossref_primary_10_1016_j_jns_2020_117074 crossref_primary_10_1038_s41394_021_00419_0 crossref_primary_10_1038_s41584_021_00608_z crossref_primary_10_1111_cen3_12678 crossref_primary_10_1136_bmjno_2024_000925 crossref_primary_10_3389_fneur_2020_573421 crossref_primary_10_1016_j_jns_2025_123588 crossref_primary_10_1007_s40120_023_00546_w crossref_primary_10_3389_fneur_2022_856091 crossref_primary_10_1136_practneurol_2017_001789 crossref_primary_10_1177_20503121241239538 crossref_primary_10_1186_s12883_025_04180_x crossref_primary_10_1080_01616412_2021_1948750 crossref_primary_10_7759_cureus_71683 crossref_primary_10_1111_jns_12482 crossref_primary_10_1212_WNL_0000000000009180 crossref_primary_10_1016_j_pneurobio_2022_102282 crossref_primary_10_1186_s12974_017_1001_8 crossref_primary_10_1093_brain_awy232 crossref_primary_10_3389_fneur_2023_1288546 crossref_primary_10_1073_pnas_1901841116 crossref_primary_10_1155_2018_5703279 crossref_primary_10_5005_jp_journals_11006_0178 crossref_primary_10_1007_s13365_024_01237_4 crossref_primary_10_5937_mckg53_23503 crossref_primary_10_1093_brain_awaa240 crossref_primary_10_1111_jns_12234 crossref_primary_10_1155_ane_2063433 crossref_primary_10_1080_17843286_2019_1708124 crossref_primary_10_1186_s12883_025_04029_3 crossref_primary_10_7759_cureus_29977 crossref_primary_10_1007_s42399_023_01444_w crossref_primary_10_7705_biomedica_6366 crossref_primary_10_3390_diagnostics15151900 crossref_primary_10_7759_cureus_30717 crossref_primary_10_1111_tmi_13181 crossref_primary_10_1016_j_clineuro_2023_108026 crossref_primary_10_1016_j_vaccine_2020_06_038 crossref_primary_10_7759_cureus_24049 crossref_primary_10_1136_bmjno_2025_001074 crossref_primary_10_1097_MS9_0000000000000841 crossref_primary_10_1007_s40263_016_0392_x crossref_primary_10_1016_j_mayocpiqo_2025_100609 crossref_primary_10_1136_bmjno_2024_000907 crossref_primary_10_7759_cureus_57174 crossref_primary_10_3390_neurolint15040086 crossref_primary_10_1002_mus_26800 crossref_primary_10_1097_NRL_0000000000000183 crossref_primary_10_1016_j_neucli_2025_103071 crossref_primary_10_1684_ecn_2019_0424 crossref_primary_10_1016_j_nerep_2022_100083 crossref_primary_10_1159_000499901 crossref_primary_10_1016_j_neuroscience_2025_08_051 crossref_primary_10_3390_life11020167 crossref_primary_10_1038_s41598_021_98501_y crossref_primary_10_25259_JNRP_2022_6_26 crossref_primary_10_3390_ctn6010007 crossref_primary_10_1093_milmed_usaf426 crossref_primary_10_1080_17843286_2020_1740858 crossref_primary_10_7759_cureus_83517 crossref_primary_10_3390_vaccines8030431 crossref_primary_10_3389_fped_2022_1008996 crossref_primary_10_3390_pathogens13020177 crossref_primary_10_1684_ecn_2019_0433 crossref_primary_10_3390_diseases13090306 crossref_primary_10_7861_clinmed_2020_0213 crossref_primary_10_1097_PCC_0000000000001935 crossref_primary_10_3390_jcm12030907 crossref_primary_10_1097_MD_0000000000043824 crossref_primary_10_1001_jamanetworkopen_2022_32571 crossref_primary_10_1097_MD_0000000000018619 crossref_primary_10_1093_infdis_jix511 crossref_primary_10_1155_2018_4286364 crossref_primary_10_3389_fphar_2022_774170 crossref_primary_10_1080_01616412_2021_2024732 crossref_primary_10_1186_s41983_018_0007_1 crossref_primary_10_1002_mus_26706 crossref_primary_10_1007_s00415_020_10124_x crossref_primary_10_1186_s12885_021_08884_4 crossref_primary_10_3389_fneur_2018_00399 crossref_primary_10_1177_0883073817700603 crossref_primary_10_1080_01616412_2021_2024725 crossref_primary_10_3389_fneur_2021_729252 crossref_primary_10_1016_j_micpath_2021_105265 crossref_primary_10_3390_children9121969 crossref_primary_10_1007_s13311_022_01253_4 crossref_primary_10_1177_0049475519836038 crossref_primary_10_1007_s00431_019_03435_3 crossref_primary_10_1155_2021_8816104 crossref_primary_10_1016_j_ensci_2025_100551 crossref_primary_10_7759_cureus_83981 crossref_primary_10_1186_s43161_024_00258_8 crossref_primary_10_3390_ijms242417520 crossref_primary_10_1007_s12028_022_01457_8 crossref_primary_10_1097_MD_0000000000027351 crossref_primary_10_12998_wjcc_v5_i7_270 crossref_primary_10_3389_fneur_2020_589928 crossref_primary_10_3389_fneur_2024_1360164 crossref_primary_10_1136_bcr_2020_240178 crossref_primary_10_18597_rcog_3611 crossref_primary_10_1002_ccr3_7863 crossref_primary_10_1002_ccr3_4597 crossref_primary_10_1016_j_heliyon_2024_e41455 crossref_primary_10_1097_WNP_0000000000000985 crossref_primary_10_1111_jns_12412 crossref_primary_10_1016_j_jocn_2018_11_031 crossref_primary_10_3389_fimmu_2022_808131 crossref_primary_10_1111_ene_15334 crossref_primary_10_1136_bcr_2018_228220 crossref_primary_10_1007_s10072_020_04693_y crossref_primary_10_1002_acn3_687 crossref_primary_10_1093_brain_awab068 crossref_primary_10_1093_jscr_rjad254 crossref_primary_10_3389_fimmu_2023_1258579 crossref_primary_10_3389_fnmol_2018_00116 crossref_primary_10_2478_jccm_2020_0038 crossref_primary_10_1186_s13052_021_01066_9 crossref_primary_10_3201_eid2401_171331 crossref_primary_10_1590_1806_9282_20200969 crossref_primary_10_3389_fneur_2024_1368706 crossref_primary_10_1016_j_jns_2021_117589 crossref_primary_10_4103_aian_AIAN_721_20 crossref_primary_10_1002_jnr_24073 crossref_primary_10_1002_jca_22043 crossref_primary_10_1080_14728222_2024_2330435 crossref_primary_10_1097_MS9_0000000000002197 crossref_primary_10_1007_s00415_021_10458_0 crossref_primary_10_1097_MD_0000000000040970 crossref_primary_10_1097_ICU_0000000000000611 crossref_primary_10_3389_fneur_2022_908282 crossref_primary_10_1111_imr_13059 crossref_primary_10_1371_journal_pone_0245826 crossref_primary_10_5005_jp_journals_10071_23187 crossref_primary_10_1177_17562864251314746 crossref_primary_10_1038_s41598_025_96231_z crossref_primary_10_1371_journal_pntd_0012898 crossref_primary_10_1159_000541303 crossref_primary_10_3389_fimmu_2022_833548 crossref_primary_10_3389_fmicb_2023_1220579 crossref_primary_10_1186_s12916_016_0660_0 crossref_primary_10_1371_journal_pone_0313545 crossref_primary_10_1186_s41983_020_0154_z crossref_primary_10_1097_MD_0000000000041830 crossref_primary_10_4274_tnd_2023_08365 crossref_primary_10_1093_brain_awab279 crossref_primary_10_1212_WNL_0000000000207215 crossref_primary_10_1016_j_jns_2020_117263 crossref_primary_10_1002_acn3_51226 crossref_primary_10_1002_jat_3512 crossref_primary_10_1111_nhs_13022 crossref_primary_10_1097_CND_0000000000000176 crossref_primary_10_31083_j_jin2103081 crossref_primary_10_1002_acn3_52313 crossref_primary_10_1002_eji_202149653 crossref_primary_10_1136_bcr_2020_236978 crossref_primary_10_1136_jnnp_2019_322361 crossref_primary_10_1136_bcr_2024_259732 crossref_primary_10_1080_21645515_2018_1528410 crossref_primary_10_29252_ajcm_27_2_77 crossref_primary_10_7759_cureus_32559 crossref_primary_10_1016_S1474_4422_21_00041_7 crossref_primary_10_1136_bcr_2018_226634 crossref_primary_10_1002_ccr3_7456 crossref_primary_10_1136_postgradmedj_2020_139585 crossref_primary_10_1007_s00415_016_8204_2 crossref_primary_10_1016_j_jns_2022_120179 crossref_primary_10_1128_mra_00456_24 crossref_primary_10_1038_s41572_024_00580_4 crossref_primary_10_1093_intimm_dxad030 crossref_primary_10_1136_jnnp_2018_317968 crossref_primary_10_4103_ni_ni_881_22 crossref_primary_10_1186_s12883_025_04365_4 crossref_primary_10_1212_CON_0000000000001004 crossref_primary_10_1016_j_neurol_2023_02_063 crossref_primary_10_1136_bmj_l1108 crossref_primary_10_1371_journal_pmed_1002203 crossref_primary_10_1007_s00415_025_12908_5 crossref_primary_10_1016_j_neurol_2023_02_064 crossref_primary_10_3389_fneur_2022_868667 crossref_primary_10_7759_cureus_28044 crossref_primary_10_1111_ane_13294 crossref_primary_10_1097_MS9_0000000000002312 crossref_primary_10_5501_wjv_v5_i4_135 crossref_primary_10_1007_s42399_021_00855_x crossref_primary_10_1186_s13256_022_03592_4 crossref_primary_10_1007_s00415_023_11808_w crossref_primary_10_1016_j_neurol_2016_08_006 crossref_primary_10_7759_cureus_67213 crossref_primary_10_1002_jcb_30486 crossref_primary_10_1002_jmv_24563 crossref_primary_10_1016_j_jaim_2025_101159 crossref_primary_10_1016_j_neurol_2017_03_033 crossref_primary_10_1111_ped_15733 crossref_primary_10_7759_cureus_16069 crossref_primary_10_3389_fimmu_2021_730088 crossref_primary_10_1007_s41030_023_00219_x crossref_primary_10_5435_JAAOSGlobal_D_18_00082 crossref_primary_10_1016_j_msard_2021_102748 crossref_primary_10_1093_cid_ciz625 crossref_primary_10_1097_NAN_0000000000000248 crossref_primary_10_1128_jvi_01658_22 crossref_primary_10_1016_j_revmed_2021_06_013 crossref_primary_10_1159_000502570 crossref_primary_10_1093_ije_dyx181 crossref_primary_10_1007_s00415_023_11908_7 crossref_primary_10_1212_WNL_0000000000006246 crossref_primary_10_1177_0956462418779465 crossref_primary_10_1016_j_micinf_2019_04_005 crossref_primary_10_7759_cureus_79611 crossref_primary_10_1155_2023_3290956 crossref_primary_10_4103_0028_3886_359245 crossref_primary_10_1093_trstmh_trz010 crossref_primary_10_1177_0300060519893169 crossref_primary_10_1007_s13760_025_02816_w crossref_primary_10_1016_j_jaut_2020_102571 crossref_primary_10_1177_0300060520904842 crossref_primary_10_1002_brb3_70298 crossref_primary_10_1007_s10072_019_03926_z crossref_primary_10_1177_17562864241297086 crossref_primary_10_3389_fnins_2023_1159929 crossref_primary_10_1016_j_legalmed_2022_102074 crossref_primary_10_1016_j_jneuroim_2020_577218 crossref_primary_10_1016_j_jns_2017_09_001 crossref_primary_10_3390_vaccines10091517 crossref_primary_10_1212_CON_0000000000001289 crossref_primary_10_24953_turkjpediatr_2024_4658 crossref_primary_10_7759_cureus_19147 crossref_primary_10_1007_s13760_020_01421_3 crossref_primary_10_3390_tropicalmed5040150 crossref_primary_10_1186_s13052_024_01682_1 crossref_primary_10_1007_s12026_022_09272_1 crossref_primary_10_1016_j_neulet_2020_135455 crossref_primary_10_1111_eci_13218 crossref_primary_10_1089_adt_2019_914 crossref_primary_10_3390_ijms24032769 crossref_primary_10_1016_j_yexmp_2024_104942 crossref_primary_10_1016_j_jaut_2019_102339 crossref_primary_10_1016_j_expneurol_2022_114274 crossref_primary_10_1056_NEJMoa1605564 crossref_primary_10_1136_bmjopen_2018_022862 crossref_primary_10_1002_iid3_875 crossref_primary_10_1097_WCO_0000000000000363 crossref_primary_10_1097_WCO_0000000000000361 crossref_primary_10_1002_iid3_1178 crossref_primary_10_1136_jnnp_2020_323899 crossref_primary_10_1016_j_mayocp_2022_12_009 crossref_primary_10_7759_cureus_85283 crossref_primary_10_1016_j_ncl_2017_06_007 crossref_primary_10_1007_s10072_019_04077_x crossref_primary_10_1111_bcp_14112 crossref_primary_10_1097_MD_0000000000029333 crossref_primary_10_1080_00207454_2024_2401422 crossref_primary_10_3389_fnagi_2021_632673 crossref_primary_10_1097_CND_0000000000000365 crossref_primary_10_1016_j_chom_2016_03_010 crossref_primary_10_1007_s11481_020_09980_1 crossref_primary_10_3389_fnins_2025_1602112 crossref_primary_10_3389_fcimb_2020_00098 crossref_primary_10_1186_s13071_025_06773_4 crossref_primary_10_1097_MD_0000000000041677 crossref_primary_10_1016_j_ijtb_2019_12_002 crossref_primary_10_1186_s13256_021_03120_w crossref_primary_10_1007_s00415_019_09634_0 crossref_primary_10_1186_s12891_020_03864_4 crossref_primary_10_1136_bcr_2024_262702
Cites_doi	10.1136/jnnp-2014-309056 10.1093/brain/awm316 10.1016/j.vaccine.2010.06.003 10.1016/j.expneurol.2011.11.039 10.1017/S0950268898001861 10.1136/jnnp.54.11.957 10.1016/j.clinph.2013.03.025 10.1016/S1474-4422(07)70130-8 10.1002/ana.410270707 10.1093/brain/123.10.2171 10.1016/j.clinph.2004.05.009 10.1113/jphysiol.2009.171702 10.1111/j.1529-8027.2011.00328.x 10.1016/j.jns.2013.01.015 10.1128/IAI.70.9.5299-5303.2002 10.1212/01.wnl.0000436073.21406.e6 10.1212/01.WNL.0000096166.28131.4C 10.1056/NEJM199511233332102 10.1212/WNL.0000000000000566 10.1016/j.jns.2013.11.016 10.1093/brain/awf272 10.1002/14651858.CD009950.pub3 10.1136/jnnp.70.5.693 10.1016/j.nmd.2012.10.014 10.1093/brain/awq260 10.1159/000324710 10.1111/j.1529-8027.2011.00310.x 10.1212/WNL.0b013e3181cff735 10.1016/j.it.2013.05.001 10.1016/j.cbpa.2014.01.008 10.1111/j.1085-9489.2005.0010202.x 10.1016/j.expneurol.2012.03.023 10.1002/mus.21480 10.1016/S0140-6736(96)09095-2 10.1212/WNL.53.2.409 10.1093/brain/118.3.597 10.1016/S0140-6736(15)61273-9 10.1016/j.neulet.2015.01.048 10.1136/jnnp-2011-301882 10.1016/j.humimm.2014.09.010 10.1111/j.1529-8027.2012.00423.x 10.1002/ana.21976 10.1002/ana.20222 10.1212/01.WNL.0000143055.09646.31 10.1111/jns.12104 10.1212/WNL.0000000000000111 10.1038/nrneurol.2014.260 10.4103/0972-2327.91942 10.1038/nrneurol.2014.121 10.1093/brain/awm004 10.1002/14651858.CD002063.pub6 10.1136/jnnp-2012-303079 10.1016/S0140-6736(03)15324-X 10.1017/S0950268813001908 10.1001/archneur.62.8.1194 10.1136/jnnp-2014-308220 10.1093/cid/cit512 10.1016/j.lpm.2013.02.328 10.1016/j.jns.2014.05.065 10.1542/peds.2004-1324 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6 10.4103/0972-2327.93278 10.1212/WNL.0b013e3181f88345 10.1212/WNL.0000000000000581 10.1212/WNL.0b013e3182904fcc 10.1136/jnnp.2007.123943 10.1111/jns5.12051 10.1016/S1473-3099(10)70140-7 10.1371/journal.pone.0082337 10.1002/ana.410440512 10.1016/j.autrev.2014.08.005 10.1016/0022-510X(93)90324-R 10.1167/iovs.08-3333 10.1093/ilar/ilt054 10.1212/WNL.0b013e3181e07d14 10.1016/j.nmd.2013.06.006 10.3892/etm.2014.1955 10.1002/ana.24442 10.1093/brain/awt285 10.1212/WNL.51.4.1110 10.1016/S0140-6736(12)62189-8 10.1212/WNL.0000000000000481 10.1007/s00415-011-6330-4 10.1056/NEJMra1114525 10.1136/jnnp.63.4.494 10.1212/WNL.0b013e3182104407 10.1159/000430917 10.1111/jns5.12074 10.1002/ana.410400209 10.1136/practneurol-2014-000937 10.1093/oxfordjournals.aje.a112795 10.1016/S0140-6736(05)67665-9 10.1016/j.jneuroim.2007.11.017 10.1111/j.1529-8027.2009.00243.x 10.1002/14651858.CD001798.pub2 10.1212/WNL.0b013e31820e7b62 10.1136/jnnp.2008.154351 10.1093/brain/awq119 10.1111/jns5.12068 10.1212/WNL.43.10.1911
ContentType	Journal Article
Copyright	2016 Elsevier Ltd Elsevier Ltd Copyright © 2016 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited Aug 13, 2016
Copyright_xml	– notice: 2016 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2016 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited Aug 13, 2016
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7TK 7U7 7U9 7X7 7XB 88A 88C 88E 88G 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ASE AZQEC BBNVY BEC BENPR BHPHI C1K CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K6X K9- K9. KB0 KB~ LK8 M0R M0S M0T M1P M2M M2O M2P M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PSYQQ Q9U S0X 7U8 7X8 JXQ 7QO 8FD FR3 P64
DOI	10.1016/S0140-6736(16)00339-1
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database (ProQuest) Lancet Titles ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection British Nursing Index Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Newsstand Professional ProQuest Biological Science Collection Consumer Health Database ProQuest Health & Medical Collection Healthcare Administration Database (ProQuest) Medical Database ProQuest Psychology Database Research Library Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic SIRS Editorial TOXLINE MEDLINE - Academic Toxline Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials Lancet Titles elibrary ProQuest AP Science SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Newsstand Professional Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection ProQuest Medical Library ProQuest Psychology Journals ProQuest Central (Alumni) TOXLINE MEDLINE - Academic Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts
DatabaseTitleList	TOXLINE ProQuest One Psychology MEDLINE Engineering Research Database
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1474-547X
EndPage	727
ExternalDocumentID	4160231861 26948435 10_1016_S0140_6736_16_00339_1 S0140673616003391 1_s2_0_S0140673616003391
Genre	Journal Article Review
GroupedDBID	--- --K --M .1- .55 .CO .FO 0R~ 123 1B1 1P~ 1RT 1~5 29L 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 88E 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8G5 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABIVO ABJNI ABLJU ABMAC ABMZM ABOCM ABUFD ABUWG ACGFS ACGOD ACIEU ACIUM ACLOT ACPRK ACRLP ACVFH ADBBV ADCNI AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGAPS AGHFR AHHHB AHMBA AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKNYI BKOJK BKOMP BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EAU EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EWM EX3 F5P FD8 FDB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K-O K9- KOM L7B LK8 LZ2 M0R M0T M1P M2M M2O M2P M7P MJL MO0 N9A NAPCQ O-L O9- OD. OO~ OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PRG PROAC PSQYO PSYQQ R2- ROL RPZ S0X SAD SDG SEL SES SJFOW SJN SPCBC SSH SSZ T5K TLN TWZ UAP UBE UKHRP UQL UV1 WOW X7M XAX XDU YYM Z5R ZMT ~HD .GJ 04C 3EH 3O- 3V. 41~ 88A 8WZ A6W AACTN AAEJM AAKAS AAQXK AAYOK ABDBF ABTAH ABWVN ACRPL ACRZS ACUHS ADMUD ADNMO ADZCM AFCTW AFFNX AFKWA AHQJS AJJEV AJOXV AKVCP ALIPV AMFUW ARTTT ASPBG AVWKF AZFZN D0S EAP EAS EAZ EBC EBD EBU EGS EHN EIHBH EMB EMK EMOBN ENC EPL EPS EPT ESX EVS FEDTE FGOYB HVGLF HZ~ J5H M0L M41 MVM OVD PKN Q~Q RIG SDF SV3 TEORI TH9 UHU WOQ WUQ XPP YYQ ZGI ZXP ZY4 ~G0 ABLVK ABYKQ AHPSJ AJBFU XFK ZA5 9DU AAYXX ADXHL AFFHD AGQPQ AIGII CITATION CGR CUY CVF ECM EIF NPM 7QL 7QP 7TK 7U7 7U9 7XB 8FK ASE C1K FPQ H94 K6X K9. KB~ M7N MBDVC PKEHL PQEST PQUKI Q9U 7U8 7X8 JXQ PUEGO 7QO 8FD FR3 P64
ID	FETCH-LOGICAL-c582t-a3b81e1a81b22a5154365150fe3833d24e8c6629fe30f4d98024cc6fbeb4dece3
IEDL.DBID	M2P
ISICitedReferencesCount	953
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000381268700032&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0140-6736
IngestDate	Tue Oct 07 09:48:43 EDT 2025 Sat Sep 27 22:04:13 EDT 2025 Sat Nov 29 14:42:48 EST 2025 Wed Feb 19 02:42:47 EST 2025 Sat Nov 29 05:12:38 EST 2025 Tue Nov 18 22:51:05 EST 2025 Fri Feb 23 02:34:52 EST 2024 Tue Feb 25 20:09:28 EST 2025 Tue Oct 14 19:31:10 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	10045
Language	English
License	Copyright © 2016 Elsevier Ltd. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c582t-a3b81e1a81b22a5154365150fe3833d24e8c6629fe30f4d98024cc6fbeb4dece3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
OpenAccessLink	http://www.thelancet.com/article/S0140673616003391/pdf
PMID	26948435
PQID	1814223225
PQPubID	40246
PageCount	11
ParticipantIDs	proquest_miscellaneous_1815691391 proquest_miscellaneous_1812887321 proquest_journals_1814223225 pubmed_primary_26948435 crossref_primary_10_1016_S0140_6736_16_00339_1 crossref_citationtrail_10_1016_S0140_6736_16_00339_1 elsevier_sciencedirect_doi_10_1016_S0140_6736_16_00339_1 elsevier_clinicalkeyesjournals_1_s2_0_S0140673616003391 elsevier_clinicalkey_doi_10_1016_S0140_6736_16_00339_1
PublicationCentury	2000
PublicationDate	2016-08-13
PublicationDateYYYYMMDD	2016-08-13
PublicationDate_xml	– month: 08 year: 2016 text: 2016-08-13 day: 13
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England – name: London
PublicationTitle	The Lancet (British edition)
PublicationTitleAlternate	Lancet
PublicationYear	2016
Publisher	Elsevier Ltd Elsevier Limited
Publisher_xml	– name: Elsevier Ltd – name: Elsevier Limited
References	Nachamkin, Liu, Li (bib47) 2002; 70 Kaida, Morita, Kanzaki (bib55) 2004; 56 Kuitwaard, Bos-Eyssen, Blomkwist-Markens, van Doorn (bib35) 2009; 14 Uncini (bib60) 2012; 235 bib34 Naik, Saroja, Patil (bib20) 2012; 15 van Koningsveld, Schmitz, Meché, Visser, Meulstee, van Doorn (bib87) 2004; 363 Sejvar, Kohl, Gidudu (bib65) 2011; 29 Rajabally, Uncini (bib13) 2012; 83 Asbury, Cornblath (bib1) 1990; 27 Hughes, Swan, van Doorn (bib12) 2014; 9 Soliven (bib40) 2014; 54 Netto, Taly, Kulkarni, Rao, Rao (bib94) 2011; 14 Darweesh, Polinder, Mulder (bib97) 2014; 19 Feasby, Hahn, Brown, Bolton, Gilbert, Koopman (bib37) 1993; 116 Hughes, Wijdicks, Benson (bib11) 2005; 62 van den Berg, Fokke, Drenthen, van Doorn, Jacobs (bib67) 2014; 82 Susuki, Yuki, Schafer (bib41) 2012; 233 van Doorn (bib66) 2013; 42 Musso, Cao-Lormeau, Gubler (bib28) 2015; 386 Salmon, Proschan, Forshee (bib33) 2013; 381 Rinaldi, Brennan, Kalna (bib56) 2013; 8 Huang, Lu, Chen (bib17) 2015; 44 Vucic, Cairns, Black, Chong, Cros (bib78) 2004; 115 Sejvar, Baughman, Wise, Morgan (bib15) 2011; 36 Blum, McCombe (bib6) 2014; 19 Bernsen, de Jager, Schmitz, van der Meché (bib100) 1999; 53 Galban-Horcajo, Halstead, McGonigal, Willison (bib57) 2014; 18 Sawai, Satoh, Mori (bib50) 2014; 83 Kokubun, Nishibayashi, Uncini, Odaka, Hirata, Yuki (bib64) 2010; 133 Walgaard, Lingsma, Ruts, van Doorn, Steyerberg, Jacobs (bib14) 2011; 76 Raphaël, Chevret, Hughes, Annane (bib83) 2012; 7 Schonberger, Bregman, Sullivan-Bolyai (bib31) 1979; 110 Geurtsvankessel, Islam, Mohammad, Jacobs, Endtz, Osterhaus (bib26) 2013; 57 Hughes, Cornblath (bib3) 2005; 366 Hadden, Cornblath, Hughes (bib58) 1998; 44 Samukawa, Hamada, Kuwahara (bib52) 2014; 337 van den Berg, van der Eijk, Pas (bib27) 2014; 82 Stathopoulos, Alexopoulos, Dalakas (bib61) 2015; 11 Islam, Jacobs, van Belkum (bib23) 2010; 74 McGonigal, Rowan, Greenshields (bib44) 2010; 133 Willison, Goodyear (bib5) 2013; 34 Cashman, Höke (bib63) 2015; 596 Chiba, Kusunoki, Obata, Machinami, Kanazawa (bib54) 1993; 43 Umapathi, Tan, Kokubun, Verma, Yuki (bib59) 2012; 83 Mori, Kuwabara, Miyake (bib25) 2000; 123 Halstead, Zitman, Humphreys (bib91) 2008; 131 Uncini, Susuki, Yuki (bib62) 2013; 124 Jacobs, van Doorn, Schmitz (bib30) 1996; 40 Benamer, Bredan (bib95) 2014; 343 Webb, Brain, Wood, Rinaldi, Turner (bib16) 2015; 86 Funakoshi, Kuwabara, Odaka, Hirata, Yuki (bib74) 2009; 80 Yang, Huan, Jiang, Song, Zhong, Liang (bib72) 2014; 8 Vanhoutte, Faber, Merkies (bib101) 2013; 23 Wakerley, Yuki (bib2) 2015; 15 Koga, Ang, Yuki (bib39) 2001; 70 Willison (bib10) 2011; 16 Makowska, Pritchard, Sanvito (bib48) 2008; 79 Liu, Willison, Pedrosa-Domellöf (bib46) 2009; 50 Kaida, Kusunoki (bib53) 2013; 65 (bib88) 1997; 349 Rees, Soudain, Gregson, Hughes (bib24) 1995; 333 Jacobs, Rothbarth, van der Meché (bib22) 1998; 51 Ruts, Drenthen, Jongen (bib68) 2010; 75 Walgaard, Lingsma, Ruts (bib81) 2010; 67 Lim, Devaux, Yuki (bib9) 2014; 13 Willison, Scherer (bib49) 2014; 83 Yuki, Hartung (bib103) 2012; 366 Hughes, Swan, Raphael, Annane, van Koningsveld, van Doorn (bib84) 2007; 130 Lehmann, Hartung, Kieseier, Hughes (bib32) 2010; 10 Drenthen, Jacobs, Maathuis, van Doorn, Visser, Blok (bib98) 2013; 81 van den Berg, Bunschoten, van Doorn, Jacobs (bib96) 2013; 80 Kleyweg, van der Meché (bib92) 1991; 54 Merkies, Faber (bib99) 2012; 22 Lyu, Tang, Cheng, Hsu, Chen (bib73) 1997; 63 Jackson, Zegarra, López-Gatell (bib18) 2014; 142 Jacobs, Koga, van Rijs (bib43) 2008; 194 Uncini, Zappasodi, Notturno (bib80) 2015; 86 Willison (bib42) 2012; 17 Ruts, Drenthen, Jacobs, van Doorn (bib89) 2010; 74 Dionne, Nicolle, Hahn (bib93) 2010; 41 Ho, Willison, Nachamkin (bib29) 1999; 45 Willison, Yuki (bib38) 2002; 125 Plomp, Willison (bib45) 2009; 587 Yuki, Kokubun, Kuwabara (bib69) 2012; 259 Huizinga, van den Berg, van Rijs (bib7) 2015; 78 Oh, Kurokawa, de Almeida, Ryan, Claussen (bib70) 2003; 61 Fitzpatrick, Mann, Barry, Brennan, Overell, Willison (bib90) 2011; 16 van Koningsveld, Steyerberg, Hughes, Swan, van Doorn, Jacobs (bib102) 2007; 6 Willison (bib36) 2005; 10 Wong, Umapathi, Nishimoto, Wang, Chan, Yuki (bib71) 2015; 20 Miyaji, Shahrizaila, Umapathi, Chan, Hirata, Yuki (bib51) 2014; 75 Korinthenberg, Schessl, Kirschner, Mönting (bib85) 2005; 116 van den Berg, Walgaard, Drenthen, Fokke, Jacobs, van Doorn (bib4) 2014; 10 McCarthy, Andersson, Jormanainen, Gustavsson, Giesecke (bib21) 1999; 122 Roodbol, de Wit, Walgaard, de Hoog, Catsman-Berrevoets, Jacobs (bib76) 2011; 76 Fokke, van den Berg, Drenthen, Walgaard, van Doorn, Jacobs (bib8) 2014; 137 Roodbol, de Wit, Aarsen, Catsman-Berrevoets, Jacobs (bib75) 2014; 19 Hughes, van Doorn (bib86) 2012; 8 Kokubun, Shahrizaila, Hirata, Yuki (bib79) 2013; 326 Ho, Mishu, Li (bib77) 1995; 118 Liu, Wang, McNicol (bib82) 2015; 4 Geleijns, Brouwer, Jacobs, Houwing-Duistermaat, van Duijn, van Doorn (bib19) 2004; 63 Rinaldi (10.1016/S0140-6736(16)00339-1_bib56) 2013; 8 Fitzpatrick (10.1016/S0140-6736(16)00339-1_bib90) 2011; 16 McGonigal (10.1016/S0140-6736(16)00339-1_bib44) 2010; 133 Jackson (10.1016/S0140-6736(16)00339-1_bib18) 2014; 142 van den Berg (10.1016/S0140-6736(16)00339-1_bib4) 2014; 10 Uncini (10.1016/S0140-6736(16)00339-1_bib62) 2013; 124 Drenthen (10.1016/S0140-6736(16)00339-1_bib98) 2013; 81 Yuki (10.1016/S0140-6736(16)00339-1_bib69) 2012; 259 Korinthenberg (10.1016/S0140-6736(16)00339-1_bib85) 2005; 116 van Koningsveld (10.1016/S0140-6736(16)00339-1_bib102) 2007; 6 Blum (10.1016/S0140-6736(16)00339-1_bib6) 2014; 19 Darweesh (10.1016/S0140-6736(16)00339-1_bib97) 2014; 19 Dionne (10.1016/S0140-6736(16)00339-1_bib93) 2010; 41 Soliven (10.1016/S0140-6736(16)00339-1_bib40) 2014; 54 Plomp (10.1016/S0140-6736(16)00339-1_bib45) 2009; 587 Schonberger (10.1016/S0140-6736(16)00339-1_bib31) 1979; 110 Musso (10.1016/S0140-6736(16)00339-1_bib28) 2015; 386 Raphaël (10.1016/S0140-6736(16)00339-1_bib83) 2012; 7 Makowska (10.1016/S0140-6736(16)00339-1_bib48) 2008; 79 Merkies (10.1016/S0140-6736(16)00339-1_bib99) 2012; 22 van den Berg (10.1016/S0140-6736(16)00339-1_bib27) 2014; 82 Samukawa (10.1016/S0140-6736(16)00339-1_bib52) 2014; 337 Sawai (10.1016/S0140-6736(16)00339-1_bib50) 2014; 83 Ruts (10.1016/S0140-6736(16)00339-1_bib89) 2010; 74 Galban-Horcajo (10.1016/S0140-6736(16)00339-1_bib57) 2014; 18 Benamer (10.1016/S0140-6736(16)00339-1_bib95) 2014; 343 Hughes (10.1016/S0140-6736(16)00339-1_bib12) 2014; 9 Rajabally (10.1016/S0140-6736(16)00339-1_bib13) 2012; 83 Oh (10.1016/S0140-6736(16)00339-1_bib70) 2003; 61 Jacobs (10.1016/S0140-6736(16)00339-1_bib43) 2008; 194 Hadden (10.1016/S0140-6736(16)00339-1_bib58) 1998; 44 Webb (10.1016/S0140-6736(16)00339-1_bib16) 2015; 86 Walgaard (10.1016/S0140-6736(16)00339-1_bib81) 2010; 67 Kleyweg (10.1016/S0140-6736(16)00339-1_bib92) 1991; 54 Sejvar (10.1016/S0140-6736(16)00339-1_bib15) 2011; 36 McCarthy (10.1016/S0140-6736(16)00339-1_bib21) 1999; 122 Asbury (10.1016/S0140-6736(16)00339-1_bib1) 1990; 27 Willison (10.1016/S0140-6736(16)00339-1_bib5) 2013; 34 Feasby (10.1016/S0140-6736(16)00339-1_bib37) 1993; 116 Lyu (10.1016/S0140-6736(16)00339-1_bib73) 1997; 63 Walgaard (10.1016/S0140-6736(16)00339-1_bib14) 2011; 76 Uncini (10.1016/S0140-6736(16)00339-1_bib60) 2012; 235 Kokubun (10.1016/S0140-6736(16)00339-1_bib79) 2013; 326 Huang (10.1016/S0140-6736(16)00339-1_bib17) 2015; 44 Halstead (10.1016/S0140-6736(16)00339-1_bib91) 2008; 131 Hughes (10.1016/S0140-6736(16)00339-1_bib11) 2005; 62 Netto (10.1016/S0140-6736(16)00339-1_bib94) 2011; 14 Geurtsvankessel (10.1016/S0140-6736(16)00339-1_bib26) 2013; 57 Willison (10.1016/S0140-6736(16)00339-1_bib38) 2002; 125 Fokke (10.1016/S0140-6736(16)00339-1_bib8) 2014; 137 Kaida (10.1016/S0140-6736(16)00339-1_bib55) 2004; 56 Hughes (10.1016/S0140-6736(16)00339-1_bib3) 2005; 366 Willison (10.1016/S0140-6736(16)00339-1_bib42) 2012; 17 Nachamkin (10.1016/S0140-6736(16)00339-1_bib47) 2002; 70 van Koningsveld (10.1016/S0140-6736(16)00339-1_bib87) 2004; 363 Kuitwaard (10.1016/S0140-6736(16)00339-1_bib35) 2009; 14 Willison (10.1016/S0140-6736(16)00339-1_bib10) 2011; 16 Jacobs (10.1016/S0140-6736(16)00339-1_bib22) 1998; 51 Liu (10.1016/S0140-6736(16)00339-1_bib82) 2015; 4 van Doorn (10.1016/S0140-6736(16)00339-1_bib66) 2013; 42 Hughes (10.1016/S0140-6736(16)00339-1_bib84) 2007; 130 Koga (10.1016/S0140-6736(16)00339-1_bib39) 2001; 70 Sejvar (10.1016/S0140-6736(16)00339-1_bib65) 2011; 29 Willison (10.1016/S0140-6736(16)00339-1_bib36) 2005; 10 Bernsen (10.1016/S0140-6736(16)00339-1_bib100) 1999; 53 Yang (10.1016/S0140-6736(16)00339-1_bib72) 2014; 8 Lim (10.1016/S0140-6736(16)00339-1_bib9) 2014; 13 Umapathi (10.1016/S0140-6736(16)00339-1_bib59) 2012; 83 Roodbol (10.1016/S0140-6736(16)00339-1_bib76) 2011; 76 (10.1016/S0140-6736(16)00339-1_bib88) 1997; 349 Hughes (10.1016/S0140-6736(16)00339-1_bib86) 2012; 8 Wong (10.1016/S0140-6736(16)00339-1_bib71) 2015; 20 Jacobs (10.1016/S0140-6736(16)00339-1_bib30) 1996; 40 Mori (10.1016/S0140-6736(16)00339-1_bib25) 2000; 123 Ho (10.1016/S0140-6736(16)00339-1_bib29) 1999; 45 Salmon (10.1016/S0140-6736(16)00339-1_bib33) 2013; 381 Huizinga (10.1016/S0140-6736(16)00339-1_bib7) 2015; 78 Cashman (10.1016/S0140-6736(16)00339-1_bib63) 2015; 596 Kaida (10.1016/S0140-6736(16)00339-1_bib53) 2013; 65 Geleijns (10.1016/S0140-6736(16)00339-1_bib19) 2004; 63 Miyaji (10.1016/S0140-6736(16)00339-1_bib51) 2014; 75 Chiba (10.1016/S0140-6736(16)00339-1_bib54) 1993; 43 Funakoshi (10.1016/S0140-6736(16)00339-1_bib74) 2009; 80 Wakerley (10.1016/S0140-6736(16)00339-1_bib2) 2015; 15 Naik (10.1016/S0140-6736(16)00339-1_bib20) 2012; 15 Rees (10.1016/S0140-6736(16)00339-1_bib24) 1995; 333 Uncini (10.1016/S0140-6736(16)00339-1_bib80) 2015; 86 Islam (10.1016/S0140-6736(16)00339-1_bib23) 2010; 74 van den Berg (10.1016/S0140-6736(16)00339-1_bib67) 2014; 82 Yuki (10.1016/S0140-6736(16)00339-1_bib103) 2012; 366 Liu (10.1016/S0140-6736(16)00339-1_bib46) 2009; 50 Vucic (10.1016/S0140-6736(16)00339-1_bib78) 2004; 115 Stathopoulos (10.1016/S0140-6736(16)00339-1_bib61) 2015; 11 van den Berg (10.1016/S0140-6736(16)00339-1_bib96) 2013; 80 Kokubun (10.1016/S0140-6736(16)00339-1_bib64) 2010; 133 Ho (10.1016/S0140-6736(16)00339-1_bib77) 1995; 118 Willison (10.1016/S0140-6736(16)00339-1_bib49) 2014; 83 Susuki (10.1016/S0140-6736(16)00339-1_bib41) 2012; 233 Ruts (10.1016/S0140-6736(16)00339-1_bib68) 2010; 75 Roodbol (10.1016/S0140-6736(16)00339-1_bib75) 2014; 19 Vanhoutte (10.1016/S0140-6736(16)00339-1_bib101) 2013; 23 Lehmann (10.1016/S0140-6736(16)00339-1_bib32) 2010; 10 28118914 - Lancet. 2017 Jan 21;389(10066):252-253 28118916 - Lancet. 2017 Jan 21;389(10066):253
References_xml	– volume: 27 start-page: S21 year: 1990 end-page: S24 ident: bib1 article-title: Assessment of current diagnostic criteria for Guillain-Barré syndrome publication-title: Ann Neurol – volume: 6 start-page: 589 year: 2007 end-page: 594 ident: bib102 article-title: A clinical prognostic scoring system for Guillain-Barré syndrome publication-title: Lancet Neurol – volume: 86 start-page: 5 year: 2015 end-page: 8 ident: bib80 article-title: Electrodiagnosis of GBS subtypes by a single study: not yet the squaring of the circle publication-title: J Neurol Neurosurg Psychiatry – volume: 110 start-page: 105 year: 1979 end-page: 123 ident: bib31 article-title: Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977 publication-title: Am J Epidemiol – volume: 74 start-page: 581 year: 2010 end-page: 587 ident: bib23 article-title: Axonal variant of Guillain-Barre syndrome associated with publication-title: Neurology – volume: 235 start-page: 513 year: 2012 end-page: 516 ident: bib60 article-title: A common mechanism and a new categorization for anti-ganglioside antibody-mediated neuropathies publication-title: Exp Neurol – volume: 51 start-page: 1110 year: 1998 end-page: 1115 ident: bib22 article-title: The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study publication-title: Neurology – volume: 65 start-page: 413 year: 2013 end-page: 423 ident: bib53 article-title: Immune-mediated neuropathy and anti-glycolipid antibodies publication-title: Brain Nerve – volume: 23 start-page: 924 year: 2013 end-page: 933 ident: bib101 article-title: 196th ENMC international workshop: outcome measures in inflammatory peripheral neuropathies 8–10 February 2013, Naarden, The Netherlands publication-title: Neuromuscul Disord – volume: 62 start-page: 1194 year: 2005 end-page: 1198 ident: bib11 article-title: Supportive care for patients with Guillain-Barré syndrome publication-title: Arch Neurol – volume: 381 start-page: 1461 year: 2013 end-page: 1468 ident: bib33 article-title: Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis publication-title: Lancet – volume: 42 start-page: e193 year: 2013 end-page: e201 ident: bib66 article-title: Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS) publication-title: Presse Med – volume: 343 start-page: 221 year: 2014 end-page: 223 ident: bib95 article-title: Guillain-Barré syndrome in Arab countries: a systematic review publication-title: J Neurol Sci – volume: 44 start-page: 249 year: 2015 end-page: 254 ident: bib17 article-title: A 15-year nationwide epidemiological analysis of Guillain-Barré syndrome in Taiwan publication-title: Neuroepidemiology – volume: 80 start-page: 60 year: 2009 end-page: 64 ident: bib74 article-title: Clinical predictors of mechanical ventilation in Fisher/Guillain-Barré overlap syndrome publication-title: J Neurol Neurosurg Psychiatry – volume: 14 start-page: 262 year: 2011 end-page: 266 ident: bib94 article-title: Mortality in mechanically ventilated patients of Guillain Barré Syndrome publication-title: Ann Indian Acad Neurol – volume: 16 start-page: 60 year: 2011 end-page: 62 ident: bib10 article-title: Biomarkers in experimental models of antibody-mediated neuropathies publication-title: J Peripher Nerv Syst – volume: 125 start-page: 2591 year: 2002 end-page: 2625 ident: bib38 article-title: Peripheral neuropathies and anti-glycolipid antibodies publication-title: Brain – volume: 142 start-page: 1089 year: 2014 end-page: 1099 ident: bib18 article-title: Binational outbreak of Guillain-Barré syndrome associated with publication-title: Epidemiol Infect – volume: 130 start-page: 2245 year: 2007 end-page: 2257 ident: bib84 article-title: Immunotherapy for Guillain-Barré syndrome: a systematic review publication-title: Brain – volume: 386 start-page: 243 year: 2015 end-page: 244 ident: bib28 article-title: Zika virus: following the path of dengue and chikungunya? publication-title: Lancet – volume: 75 start-page: 1439 year: 2010 end-page: 1447 ident: bib68 article-title: Pain in Guillain-Barre syndrome: a long-term follow-up study publication-title: Neurology – volume: 137 start-page: 33 year: 2014 end-page: 43 ident: bib8 article-title: Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria publication-title: Brain – volume: 16 start-page: 84 year: 2011 end-page: 91 ident: bib90 article-title: An open label clinical trial of complement inhibition in multifocal motor neuropathy publication-title: J Peripher Nerv Syst – volume: 10 start-page: 469 year: 2014 end-page: 482 ident: bib4 article-title: Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis publication-title: Nat Rev Neurol – volume: 15 start-page: 44 year: 2012 end-page: 47 ident: bib20 article-title: Familial Guillain-Barré syndrome: first Indian report publication-title: Ann Indian Acad Neurol – volume: 124 start-page: 1928 year: 2013 end-page: 1934 ident: bib62 article-title: Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies publication-title: Clin Neurophysiol – volume: 43 start-page: 1911 year: 1993 end-page: 1917 ident: bib54 article-title: Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies publication-title: Neurology – volume: 123 start-page: 2171 year: 2000 end-page: 2178 ident: bib25 article-title: infection and Guillain-Barré syndrome publication-title: Brain – volume: 326 start-page: 111 year: 2013 end-page: 114 ident: bib79 article-title: Reversible conduction failure is distinct from neurophysiological patterns of recovery in mild demyelinating Guillain-Barré syndrome publication-title: J Neurol Sci – volume: 596 start-page: 33 year: 2015 end-page: 50 ident: bib63 article-title: Mechanisms of distal axonal degeneration in peripheral neuropathies publication-title: Neurosci Lett – volume: 366 start-page: 1653 year: 2005 end-page: 1666 ident: bib3 article-title: Guillain-Barré syndrome publication-title: Lancet – volume: 19 start-page: 24 year: 2014 end-page: 35 ident: bib97 article-title: Health-related quality of life in Guillain-Barré syndrome patients: a systematic review publication-title: J Peripher Nerv Syst – volume: 19 start-page: 88 year: 2014 end-page: 103 ident: bib6 article-title: Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions publication-title: J Peripher Nerv Syst – volume: 133 start-page: 1944 year: 2010 end-page: 1960 ident: bib44 article-title: Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice publication-title: Brain – volume: 74 start-page: 1680 year: 2010 end-page: 1686 ident: bib89 article-title: Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study publication-title: Neurology – volume: 79 start-page: 664 year: 2008 end-page: 671 ident: bib48 article-title: Immune responses to myelin proteins in Guillain-Barré syndrome publication-title: J Neurol Neurosurg Psychiatry – volume: 45 start-page: 168 year: 1999 end-page: 173 ident: bib29 article-title: Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome publication-title: Ann Neurol – volume: 82 start-page: 491 year: 2014 end-page: 497 ident: bib27 article-title: Guillain-Barré syndrome associated with preceding hepatitis E virus infection publication-title: Neurology – volume: 15 start-page: 90 year: 2015 end-page: 99 ident: bib2 article-title: Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes publication-title: Pract Neurol – volume: 9 year: 2014 ident: bib12 article-title: Intravenous immunoglobulin for Guillain-Barré syndrome publication-title: Cochrane Database Syst Rev – volume: 333 start-page: 1374 year: 1995 end-page: 1379 ident: bib24 article-title: infection and Guillain-Barré syndrome publication-title: N Engl J Med – volume: 75 start-page: 1089 year: 2014 end-page: 1091 ident: bib51 article-title: Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies? publication-title: Hum Immunol – volume: 4 year: 2015 ident: bib82 article-title: Pharmacological treatment for pain in Guillain-Barré syndrome publication-title: Cochrane Database Syst Rev – volume: 67 start-page: 781 year: 2010 end-page: 787 ident: bib81 article-title: Prediction of respiratory insufficiency in Guillain-Barré syndrome publication-title: Ann Neurol – volume: 233 start-page: 534 year: 2012 end-page: 542 ident: bib41 article-title: Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies publication-title: Exp Neurol – volume: 8 start-page: 1397 year: 2014 end-page: 1401 ident: bib72 article-title: Pure sensory Guillain-Barré syndrome: a case report and review of the literature publication-title: Exp Ther Med – volume: 81 start-page: 1827 year: 2013 end-page: 1831 ident: bib98 article-title: Residual fatigue in Guillain-Barre syndrome is related to axonal loss publication-title: Neurology – volume: 54 start-page: 282 year: 2014 end-page: 290 ident: bib40 article-title: Animal models of autoimmune neuropathy publication-title: ILAR J – volume: 40 start-page: 181 year: 1996 end-page: 187 ident: bib30 article-title: infections and anti-GM1 antibodies in Guillain-Barré syndrome publication-title: Ann Neurol – volume: 50 start-page: 3226 year: 2009 end-page: 3232 ident: bib46 article-title: Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles publication-title: Invest Ophthalmol Vis Sci – volume: 349 start-page: 225 year: 1997 end-page: 230 ident: bib88 article-title: Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome publication-title: Lancet – volume: 116 start-page: 185 year: 1993 end-page: 192 ident: bib37 article-title: Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? publication-title: J Neurol Sci – volume: 115 start-page: 2329 year: 2004 end-page: 2335 ident: bib78 article-title: Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy publication-title: Clin Neurophysiol – volume: 587 start-page: 3979 year: 2009 end-page: 3999 ident: bib45 article-title: Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction publication-title: J Physiol – volume: 41 start-page: 202 year: 2010 end-page: 207 ident: bib93 article-title: Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy publication-title: Muscle Nerve – volume: 194 start-page: 181 year: 2008 end-page: 190 ident: bib43 article-title: Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome publication-title: J Neuroimmunol – volume: 18 start-page: 78 year: 2014 end-page: 86 ident: bib57 article-title: The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders publication-title: Curr Opin Chem Biol – volume: 76 start-page: 807 year: 2011 end-page: 810 ident: bib76 article-title: Recognizing Guillain-Barre syndrome in preschool children publication-title: Neurology – volume: 363 start-page: 192 year: 2004 end-page: 196 ident: bib87 article-title: Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial publication-title: Lancet – volume: 11 start-page: 143 year: 2015 end-page: 156 ident: bib61 article-title: Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders publication-title: Nat Rev Neurol – volume: 80 start-page: 1650 year: 2013 end-page: 1654 ident: bib96 article-title: Mortality in Guillain-Barre syndrome publication-title: Neurology – volume: 53 start-page: 409 year: 1999 end-page: 410 ident: bib100 article-title: Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome publication-title: Neurology – volume: 83 start-page: 113 year: 2014 end-page: 117 ident: bib50 article-title: Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome publication-title: Neurology – volume: 83 start-page: 941 year: 2012 end-page: 948 ident: bib59 article-title: Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders publication-title: J Neurol Neurosurg Psychiatry – volume: 34 start-page: 453 year: 2013 end-page: 459 ident: bib5 article-title: Glycolipid antigens and autoantibodies in autoimmune neuropathies publication-title: Trends Immunol – volume: 63 start-page: 1747 year: 2004 end-page: 1750 ident: bib19 article-title: The occurrence of Guillain-Barré syndrome within families publication-title: Neurology – volume: 61 start-page: 1507 year: 2003 end-page: 1512 ident: bib70 article-title: Subacute inflammatory demyelinating polyneuropathy publication-title: Neurology – volume: 57 start-page: 1369 year: 2013 end-page: 1370 ident: bib26 article-title: Hepatitis E and Guillain-Barre syndrome publication-title: Clin Infect Dis – volume: 122 start-page: 15 year: 1999 end-page: 17 ident: bib21 article-title: The risk of Guillain-Barré syndrome following infection with publication-title: Epidemiol Infect – volume: 13 start-page: 1070 year: 2014 end-page: 1078 ident: bib9 article-title: Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies publication-title: Autoimmun Rev – volume: 83 start-page: 106 year: 2014 end-page: 108 ident: bib49 article-title: Ranvier revisited: novel nodal antigens stimulate interest in GBS pathogenesis publication-title: Neurology – volume: 22 start-page: S203 year: 2012 end-page: S207 ident: bib99 article-title: Fatigue in immune-mediated neuropathies publication-title: Neuromuscul Disord – volume: 83 start-page: 711 year: 2012 end-page: 718 ident: bib13 article-title: Outcome and its predictors in Guillain-Barre syndrome publication-title: J Neurol Neurosurg Psychiatry – volume: 7 year: 2012 ident: bib83 article-title: Plasma exchange for Guillain-Barré syndrome publication-title: Cochrane Database Syst Rev – volume: 259 start-page: 1181 year: 2012 end-page: 1190 ident: bib69 article-title: Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes publication-title: J Neurol – volume: 76 start-page: 968 year: 2011 end-page: 975 ident: bib14 article-title: Early recognition of poor prognosis in Guillain-Barre syndrome publication-title: Neurology – volume: 70 start-page: 693 year: 2001 end-page: 695 ident: bib39 article-title: Comparative study of preceding publication-title: J Neurol Neurosurg Psychiatry – volume: 14 start-page: 310 year: 2009 end-page: 315 ident: bib35 article-title: Recurrences, vaccinations and long-term symptoms in GBS and CIDP publication-title: J Peripher Nerv Syst – volume: 131 start-page: 1197 year: 2008 end-page: 1208 ident: bib91 article-title: Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model publication-title: Brain – volume: 54 start-page: 957 year: 1991 end-page: 960 ident: bib92 article-title: Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange publication-title: J Neurol Neurosurg Psychiatry – volume: 70 start-page: 5299 year: 2002 end-page: 5303 ident: bib47 article-title: from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope publication-title: Infect Immun – volume: 366 start-page: 2294 year: 2012 end-page: 2304 ident: bib103 article-title: Guillain-Barré syndrome publication-title: N Engl J Med – volume: 337 start-page: 55 year: 2014 end-page: 60 ident: bib52 article-title: Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody publication-title: J Neurol Sci – volume: 10 start-page: 94 year: 2005 end-page: 112 ident: bib36 article-title: The immunobiology of Guillain-Barré syndromes publication-title: J Peripher Nerv Syst – ident: bib34 article-title: Guillain-Barré syndrome common concerns – volume: 56 start-page: 567 year: 2004 end-page: 571 ident: bib55 article-title: Ganglioside complexes as new target antigens in Guillain-Barré syndrome publication-title: Ann Neurol – volume: 36 start-page: 123 year: 2011 end-page: 133 ident: bib15 article-title: Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis publication-title: Neuroepidemiology – volume: 8 year: 2012 ident: bib86 article-title: Corticosteroids for Guillain-Barré syndrome publication-title: Cochrane Database Syst Rev – volume: 63 start-page: 494 year: 1997 end-page: 500 ident: bib73 article-title: Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients publication-title: J Neurol Neurosurg Psychiatry – volume: 19 start-page: 121 year: 2014 end-page: 126 ident: bib75 article-title: Long-term outcome of Guillain-Barré syndrome in children publication-title: J Peripher Nerv Syst – volume: 82 start-page: 1984 year: 2014 end-page: 1989 ident: bib67 article-title: Paraparetic Guillain-Barré syndrome publication-title: Neurology – volume: 116 start-page: 8 year: 2005 end-page: 14 ident: bib85 article-title: Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial publication-title: Pediatrics – volume: 29 start-page: 599 year: 2011 end-page: 612 ident: bib65 article-title: Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data publication-title: Vaccine – volume: 118 start-page: 597 year: 1995 end-page: 605 ident: bib77 article-title: Guillain-Barré syndrome in northern China. Relationship to publication-title: Brain – volume: 8 start-page: e82337 year: 2013 ident: bib56 article-title: Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome publication-title: PLoS One – volume: 86 start-page: 1196 year: 2015 end-page: 1201 ident: bib16 article-title: Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study publication-title: J Neurol Neurosurg Psychiatry – volume: 17 start-page: 3 year: 2012 end-page: 8 ident: bib42 article-title: The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy publication-title: J Peripher Nerv Syst – volume: 20 start-page: 47 year: 2015 end-page: 51 ident: bib71 article-title: Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes publication-title: J Peripher Nerv Syst – volume: 78 start-page: 343 year: 2015 end-page: 354 ident: bib7 article-title: Innate immunity to publication-title: Ann Neurol – volume: 133 start-page: 2897 year: 2010 end-page: 2908 ident: bib64 article-title: Conduction block in acute motor axonal neuropathy publication-title: Brain – volume: 10 start-page: 643 year: 2010 end-page: 651 ident: bib32 article-title: Guillain-Barré syndrome after exposure to influenza virus publication-title: Lancet Infect Dis – volume: 44 start-page: 780 year: 1998 end-page: 788 ident: bib58 article-title: Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome publication-title: Ann Neurol – volume: 86 start-page: 1196 year: 2015 ident: 10.1016/S0140-6736(16)00339-1_bib16 article-title: Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2014-309056 – volume: 131 start-page: 1197 year: 2008 ident: 10.1016/S0140-6736(16)00339-1_bib91 article-title: Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model publication-title: Brain doi: 10.1093/brain/awm316 – volume: 29 start-page: 599 year: 2011 ident: 10.1016/S0140-6736(16)00339-1_bib65 article-title: Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data publication-title: Vaccine doi: 10.1016/j.vaccine.2010.06.003 – volume: 233 start-page: 534 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib41 article-title: Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies publication-title: Exp Neurol doi: 10.1016/j.expneurol.2011.11.039 – volume: 122 start-page: 15 year: 1999 ident: 10.1016/S0140-6736(16)00339-1_bib21 article-title: The risk of Guillain-Barré syndrome following infection with Campylobacter jejuni publication-title: Epidemiol Infect doi: 10.1017/S0950268898001861 – volume: 54 start-page: 957 year: 1991 ident: 10.1016/S0140-6736(16)00339-1_bib92 article-title: Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.54.11.957 – volume: 124 start-page: 1928 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib62 article-title: Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies publication-title: Clin Neurophysiol doi: 10.1016/j.clinph.2013.03.025 – volume: 6 start-page: 589 year: 2007 ident: 10.1016/S0140-6736(16)00339-1_bib102 article-title: A clinical prognostic scoring system for Guillain-Barré syndrome publication-title: Lancet Neurol doi: 10.1016/S1474-4422(07)70130-8 – volume: 27 start-page: S21 issue: suppl year: 1990 ident: 10.1016/S0140-6736(16)00339-1_bib1 article-title: Assessment of current diagnostic criteria for Guillain-Barré syndrome publication-title: Ann Neurol doi: 10.1002/ana.410270707 – volume: 123 start-page: 2171 year: 2000 ident: 10.1016/S0140-6736(16)00339-1_bib25 article-title: Haemophilus influenzae infection and Guillain-Barré syndrome publication-title: Brain doi: 10.1093/brain/123.10.2171 – volume: 115 start-page: 2329 year: 2004 ident: 10.1016/S0140-6736(16)00339-1_bib78 article-title: Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy publication-title: Clin Neurophysiol doi: 10.1016/j.clinph.2004.05.009 – volume: 587 start-page: 3979 year: 2009 ident: 10.1016/S0140-6736(16)00339-1_bib45 article-title: Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction publication-title: J Physiol doi: 10.1113/jphysiol.2009.171702 – volume: 16 start-page: 84 year: 2011 ident: 10.1016/S0140-6736(16)00339-1_bib90 article-title: An open label clinical trial of complement inhibition in multifocal motor neuropathy publication-title: J Peripher Nerv Syst doi: 10.1111/j.1529-8027.2011.00328.x – volume: 326 start-page: 111 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib79 article-title: Reversible conduction failure is distinct from neurophysiological patterns of recovery in mild demyelinating Guillain-Barré syndrome publication-title: J Neurol Sci doi: 10.1016/j.jns.2013.01.015 – volume: 70 start-page: 5299 year: 2002 ident: 10.1016/S0140-6736(16)00339-1_bib47 article-title: Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope publication-title: Infect Immun doi: 10.1128/IAI.70.9.5299-5303.2002 – volume: 81 start-page: 1827 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib98 article-title: Residual fatigue in Guillain-Barre syndrome is related to axonal loss publication-title: Neurology doi: 10.1212/01.wnl.0000436073.21406.e6 – volume: 61 start-page: 1507 year: 2003 ident: 10.1016/S0140-6736(16)00339-1_bib70 article-title: Subacute inflammatory demyelinating polyneuropathy publication-title: Neurology doi: 10.1212/01.WNL.0000096166.28131.4C – volume: 333 start-page: 1374 year: 1995 ident: 10.1016/S0140-6736(16)00339-1_bib24 article-title: Campylobacter jejuni infection and Guillain-Barré syndrome publication-title: N Engl J Med doi: 10.1056/NEJM199511233332102 – volume: 83 start-page: 113 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib50 article-title: Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome publication-title: Neurology doi: 10.1212/WNL.0000000000000566 – volume: 337 start-page: 55 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib52 article-title: Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody publication-title: J Neurol Sci doi: 10.1016/j.jns.2013.11.016 – volume: 125 start-page: 2591 year: 2002 ident: 10.1016/S0140-6736(16)00339-1_bib38 article-title: Peripheral neuropathies and anti-glycolipid antibodies publication-title: Brain doi: 10.1093/brain/awf272 – volume: 4 year: 2015 ident: 10.1016/S0140-6736(16)00339-1_bib82 article-title: Pharmacological treatment for pain in Guillain-Barré syndrome publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD009950.pub3 – volume: 70 start-page: 693 year: 2001 ident: 10.1016/S0140-6736(16)00339-1_bib39 article-title: Comparative study of preceding Campylobacter jejuni infection in Guillain-Barré syndrome in Japan and The Netherlands publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.70.5.693 – volume: 22 start-page: S203 issue: suppl 3 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib99 article-title: Fatigue in immune-mediated neuropathies publication-title: Neuromuscul Disord doi: 10.1016/j.nmd.2012.10.014 – volume: 133 start-page: 2897 year: 2010 ident: 10.1016/S0140-6736(16)00339-1_bib64 article-title: Conduction block in acute motor axonal neuropathy publication-title: Brain doi: 10.1093/brain/awq260 – volume: 36 start-page: 123 year: 2011 ident: 10.1016/S0140-6736(16)00339-1_bib15 article-title: Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis publication-title: Neuroepidemiology doi: 10.1159/000324710 – volume: 16 start-page: 60 issue: suppl 1 year: 2011 ident: 10.1016/S0140-6736(16)00339-1_bib10 article-title: Biomarkers in experimental models of antibody-mediated neuropathies publication-title: J Peripher Nerv Syst doi: 10.1111/j.1529-8027.2011.00310.x – volume: 74 start-page: 581 year: 2010 ident: 10.1016/S0140-6736(16)00339-1_bib23 article-title: Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh publication-title: Neurology doi: 10.1212/WNL.0b013e3181cff735 – volume: 34 start-page: 453 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib5 article-title: Glycolipid antigens and autoantibodies in autoimmune neuropathies publication-title: Trends Immunol doi: 10.1016/j.it.2013.05.001 – volume: 18 start-page: 78 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib57 article-title: The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders publication-title: Curr Opin Chem Biol doi: 10.1016/j.cbpa.2014.01.008 – volume: 10 start-page: 94 year: 2005 ident: 10.1016/S0140-6736(16)00339-1_bib36 article-title: The immunobiology of Guillain-Barré syndromes publication-title: J Peripher Nerv Syst doi: 10.1111/j.1085-9489.2005.0010202.x – volume: 235 start-page: 513 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib60 article-title: A common mechanism and a new categorization for anti-ganglioside antibody-mediated neuropathies publication-title: Exp Neurol doi: 10.1016/j.expneurol.2012.03.023 – volume: 41 start-page: 202 year: 2010 ident: 10.1016/S0140-6736(16)00339-1_bib93 article-title: Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy publication-title: Muscle Nerve doi: 10.1002/mus.21480 – volume: 349 start-page: 225 year: 1997 ident: 10.1016/S0140-6736(16)00339-1_bib88 article-title: Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome publication-title: Lancet doi: 10.1016/S0140-6736(96)09095-2 – volume: 53 start-page: 409 year: 1999 ident: 10.1016/S0140-6736(16)00339-1_bib100 article-title: Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome publication-title: Neurology doi: 10.1212/WNL.53.2.409 – volume: 118 start-page: 597 year: 1995 ident: 10.1016/S0140-6736(16)00339-1_bib77 article-title: Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies publication-title: Brain doi: 10.1093/brain/118.3.597 – volume: 386 start-page: 243 year: 2015 ident: 10.1016/S0140-6736(16)00339-1_bib28 article-title: Zika virus: following the path of dengue and chikungunya? publication-title: Lancet doi: 10.1016/S0140-6736(15)61273-9 – volume: 596 start-page: 33 year: 2015 ident: 10.1016/S0140-6736(16)00339-1_bib63 article-title: Mechanisms of distal axonal degeneration in peripheral neuropathies publication-title: Neurosci Lett doi: 10.1016/j.neulet.2015.01.048 – volume: 83 start-page: 711 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib13 article-title: Outcome and its predictors in Guillain-Barre syndrome publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2011-301882 – volume: 75 start-page: 1089 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib51 article-title: Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies? publication-title: Hum Immunol doi: 10.1016/j.humimm.2014.09.010 – volume: 17 start-page: 3 issue: suppl 3 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib42 article-title: The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy publication-title: J Peripher Nerv Syst doi: 10.1111/j.1529-8027.2012.00423.x – volume: 67 start-page: 781 year: 2010 ident: 10.1016/S0140-6736(16)00339-1_bib81 article-title: Prediction of respiratory insufficiency in Guillain-Barré syndrome publication-title: Ann Neurol doi: 10.1002/ana.21976 – volume: 56 start-page: 567 year: 2004 ident: 10.1016/S0140-6736(16)00339-1_bib55 article-title: Ganglioside complexes as new target antigens in Guillain-Barré syndrome publication-title: Ann Neurol doi: 10.1002/ana.20222 – volume: 63 start-page: 1747 year: 2004 ident: 10.1016/S0140-6736(16)00339-1_bib19 article-title: The occurrence of Guillain-Barré syndrome within families publication-title: Neurology doi: 10.1212/01.WNL.0000143055.09646.31 – volume: 20 start-page: 47 year: 2015 ident: 10.1016/S0140-6736(16)00339-1_bib71 article-title: Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes publication-title: J Peripher Nerv Syst doi: 10.1111/jns.12104 – volume: 82 start-page: 491 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib27 article-title: Guillain-Barré syndrome associated with preceding hepatitis E virus infection publication-title: Neurology doi: 10.1212/WNL.0000000000000111 – volume: 11 start-page: 143 year: 2015 ident: 10.1016/S0140-6736(16)00339-1_bib61 article-title: Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2014.260 – volume: 14 start-page: 262 year: 2011 ident: 10.1016/S0140-6736(16)00339-1_bib94 article-title: Mortality in mechanically ventilated patients of Guillain Barré Syndrome publication-title: Ann Indian Acad Neurol doi: 10.4103/0972-2327.91942 – volume: 10 start-page: 469 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib4 article-title: Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2014.121 – volume: 130 start-page: 2245 year: 2007 ident: 10.1016/S0140-6736(16)00339-1_bib84 article-title: Immunotherapy for Guillain-Barré syndrome: a systematic review publication-title: Brain doi: 10.1093/brain/awm004 – volume: 9 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib12 article-title: Intravenous immunoglobulin for Guillain-Barré syndrome publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD002063.pub6 – volume: 83 start-page: 941 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib59 article-title: Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2012-303079 – volume: 363 start-page: 192 year: 2004 ident: 10.1016/S0140-6736(16)00339-1_bib87 article-title: Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(03)15324-X – volume: 142 start-page: 1089 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib18 article-title: Binational outbreak of Guillain-Barré syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011 publication-title: Epidemiol Infect doi: 10.1017/S0950268813001908 – volume: 62 start-page: 1194 year: 2005 ident: 10.1016/S0140-6736(16)00339-1_bib11 article-title: Supportive care for patients with Guillain-Barré syndrome publication-title: Arch Neurol doi: 10.1001/archneur.62.8.1194 – volume: 86 start-page: 5 year: 2015 ident: 10.1016/S0140-6736(16)00339-1_bib80 article-title: Electrodiagnosis of GBS subtypes by a single study: not yet the squaring of the circle publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2014-308220 – volume: 57 start-page: 1369 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib26 article-title: Hepatitis E and Guillain-Barre syndrome publication-title: Clin Infect Dis doi: 10.1093/cid/cit512 – volume: 42 start-page: e193 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib66 article-title: Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS) publication-title: Presse Med doi: 10.1016/j.lpm.2013.02.328 – volume: 343 start-page: 221 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib95 article-title: Guillain-Barré syndrome in Arab countries: a systematic review publication-title: J Neurol Sci doi: 10.1016/j.jns.2014.05.065 – volume: 116 start-page: 8 year: 2005 ident: 10.1016/S0140-6736(16)00339-1_bib85 article-title: Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial publication-title: Pediatrics doi: 10.1542/peds.2004-1324 – volume: 8 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib86 article-title: Corticosteroids for Guillain-Barré syndrome publication-title: Cochrane Database Syst Rev – volume: 45 start-page: 168 year: 1999 ident: 10.1016/S0140-6736(16)00339-1_bib29 article-title: Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome publication-title: Ann Neurol doi: 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6 – volume: 15 start-page: 44 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib20 article-title: Familial Guillain-Barré syndrome: first Indian report publication-title: Ann Indian Acad Neurol doi: 10.4103/0972-2327.93278 – volume: 75 start-page: 1439 year: 2010 ident: 10.1016/S0140-6736(16)00339-1_bib68 article-title: Pain in Guillain-Barre syndrome: a long-term follow-up study publication-title: Neurology doi: 10.1212/WNL.0b013e3181f88345 – volume: 83 start-page: 106 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib49 article-title: Ranvier revisited: novel nodal antigens stimulate interest in GBS pathogenesis publication-title: Neurology doi: 10.1212/WNL.0000000000000581 – volume: 80 start-page: 1650 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib96 article-title: Mortality in Guillain-Barre syndrome publication-title: Neurology doi: 10.1212/WNL.0b013e3182904fcc – volume: 65 start-page: 413 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib53 article-title: Immune-mediated neuropathy and anti-glycolipid antibodies publication-title: Brain Nerve – volume: 79 start-page: 664 year: 2008 ident: 10.1016/S0140-6736(16)00339-1_bib48 article-title: Immune responses to myelin proteins in Guillain-Barré syndrome publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2007.123943 – volume: 19 start-page: 24 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib97 article-title: Health-related quality of life in Guillain-Barré syndrome patients: a systematic review publication-title: J Peripher Nerv Syst doi: 10.1111/jns5.12051 – volume: 10 start-page: 643 year: 2010 ident: 10.1016/S0140-6736(16)00339-1_bib32 article-title: Guillain-Barré syndrome after exposure to influenza virus publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(10)70140-7 – volume: 8 start-page: e82337 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib56 article-title: Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome publication-title: PLoS One doi: 10.1371/journal.pone.0082337 – volume: 44 start-page: 780 year: 1998 ident: 10.1016/S0140-6736(16)00339-1_bib58 article-title: Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome publication-title: Ann Neurol doi: 10.1002/ana.410440512 – volume: 13 start-page: 1070 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib9 article-title: Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2014.08.005 – volume: 116 start-page: 185 year: 1993 ident: 10.1016/S0140-6736(16)00339-1_bib37 article-title: Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? publication-title: J Neurol Sci doi: 10.1016/0022-510X(93)90324-R – volume: 50 start-page: 3226 year: 2009 ident: 10.1016/S0140-6736(16)00339-1_bib46 article-title: Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.08-3333 – volume: 54 start-page: 282 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib40 article-title: Animal models of autoimmune neuropathy publication-title: ILAR J doi: 10.1093/ilar/ilt054 – volume: 74 start-page: 1680 year: 2010 ident: 10.1016/S0140-6736(16)00339-1_bib89 article-title: Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study publication-title: Neurology doi: 10.1212/WNL.0b013e3181e07d14 – volume: 23 start-page: 924 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib101 article-title: 196th ENMC international workshop: outcome measures in inflammatory peripheral neuropathies 8–10 February 2013, Naarden, The Netherlands publication-title: Neuromuscul Disord doi: 10.1016/j.nmd.2013.06.006 – volume: 8 start-page: 1397 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib72 article-title: Pure sensory Guillain-Barré syndrome: a case report and review of the literature publication-title: Exp Ther Med doi: 10.3892/etm.2014.1955 – volume: 78 start-page: 343 year: 2015 ident: 10.1016/S0140-6736(16)00339-1_bib7 article-title: Innate immunity to Campylobacter jejuni in Guillain-Barré syndrome publication-title: Ann Neurol doi: 10.1002/ana.24442 – volume: 137 start-page: 33 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib8 article-title: Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria publication-title: Brain doi: 10.1093/brain/awt285 – volume: 51 start-page: 1110 year: 1998 ident: 10.1016/S0140-6736(16)00339-1_bib22 article-title: The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study publication-title: Neurology doi: 10.1212/WNL.51.4.1110 – volume: 381 start-page: 1461 year: 2013 ident: 10.1016/S0140-6736(16)00339-1_bib33 article-title: Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis publication-title: Lancet doi: 10.1016/S0140-6736(12)62189-8 – volume: 82 start-page: 1984 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib67 article-title: Paraparetic Guillain-Barré syndrome publication-title: Neurology doi: 10.1212/WNL.0000000000000481 – volume: 259 start-page: 1181 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib69 article-title: Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes publication-title: J Neurol doi: 10.1007/s00415-011-6330-4 – volume: 366 start-page: 2294 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib103 article-title: Guillain-Barré syndrome publication-title: N Engl J Med doi: 10.1056/NEJMra1114525 – volume: 63 start-page: 494 year: 1997 ident: 10.1016/S0140-6736(16)00339-1_bib73 article-title: Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.63.4.494 – volume: 76 start-page: 968 year: 2011 ident: 10.1016/S0140-6736(16)00339-1_bib14 article-title: Early recognition of poor prognosis in Guillain-Barre syndrome publication-title: Neurology doi: 10.1212/WNL.0b013e3182104407 – volume: 44 start-page: 249 year: 2015 ident: 10.1016/S0140-6736(16)00339-1_bib17 article-title: A 15-year nationwide epidemiological analysis of Guillain-Barré syndrome in Taiwan publication-title: Neuroepidemiology doi: 10.1159/000430917 – volume: 19 start-page: 88 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib6 article-title: Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions publication-title: J Peripher Nerv Syst doi: 10.1111/jns5.12074 – volume: 40 start-page: 181 year: 1996 ident: 10.1016/S0140-6736(16)00339-1_bib30 article-title: Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome publication-title: Ann Neurol doi: 10.1002/ana.410400209 – volume: 15 start-page: 90 year: 2015 ident: 10.1016/S0140-6736(16)00339-1_bib2 article-title: Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes publication-title: Pract Neurol doi: 10.1136/practneurol-2014-000937 – volume: 110 start-page: 105 year: 1979 ident: 10.1016/S0140-6736(16)00339-1_bib31 article-title: Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a112795 – volume: 366 start-page: 1653 year: 2005 ident: 10.1016/S0140-6736(16)00339-1_bib3 article-title: Guillain-Barré syndrome publication-title: Lancet doi: 10.1016/S0140-6736(05)67665-9 – volume: 194 start-page: 181 year: 2008 ident: 10.1016/S0140-6736(16)00339-1_bib43 article-title: Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2007.11.017 – volume: 14 start-page: 310 year: 2009 ident: 10.1016/S0140-6736(16)00339-1_bib35 article-title: Recurrences, vaccinations and long-term symptoms in GBS and CIDP publication-title: J Peripher Nerv Syst doi: 10.1111/j.1529-8027.2009.00243.x – volume: 7 year: 2012 ident: 10.1016/S0140-6736(16)00339-1_bib83 article-title: Plasma exchange for Guillain-Barré syndrome publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD001798.pub2 – volume: 76 start-page: 807 year: 2011 ident: 10.1016/S0140-6736(16)00339-1_bib76 article-title: Recognizing Guillain-Barre syndrome in preschool children publication-title: Neurology doi: 10.1212/WNL.0b013e31820e7b62 – volume: 80 start-page: 60 year: 2009 ident: 10.1016/S0140-6736(16)00339-1_bib74 article-title: Clinical predictors of mechanical ventilation in Fisher/Guillain-Barré overlap syndrome publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2008.154351 – volume: 133 start-page: 1944 year: 2010 ident: 10.1016/S0140-6736(16)00339-1_bib44 article-title: Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice publication-title: Brain doi: 10.1093/brain/awq119 – volume: 19 start-page: 121 year: 2014 ident: 10.1016/S0140-6736(16)00339-1_bib75 article-title: Long-term outcome of Guillain-Barré syndrome in children publication-title: J Peripher Nerv Syst doi: 10.1111/jns5.12068 – volume: 43 start-page: 1911 year: 1993 ident: 10.1016/S0140-6736(16)00339-1_bib54 article-title: Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies publication-title: Neurology doi: 10.1212/WNL.43.10.1911 – reference: 28118916 - Lancet. 2017 Jan 21;389(10066):253 – reference: 28118914 - Lancet. 2017 Jan 21;389(10066):252-253
SSID	ssj0004605
Score	2.6851473
SecondaryResourceType	review_article
Snippet	Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 100 000 people developing the disorder every year worldwide.... Summary Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 100 000 people developing the disorder every year... Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 100,000 people developing the disorder every year worldwide.... Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 100 000 people developing the disorder every year worldwide.... Guillain-Barre syndrome is the most common and most severe acute paralytic neuropathy, with about 100000 people developing the disorder every year worldwide....
SourceID	proquest pubmed crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	717
SubjectTerms	Axons - immunology Axons - pathology Biomarkers Campylobacter Infections - complications Campylobacter Infections - immunology Campylobacter jejuni Clinical Trials as Topic Diagnosis, Differential Disease Management Electrophysiology Epidemiology Guillain-Barre syndrome Guillain-Barre Syndrome - complications Guillain-Barre Syndrome - diagnosis Guillain-Barre Syndrome - epidemiology Guillain-Barre Syndrome - immunology Guillain-Barre Syndrome - physiopathology Guillain-Barre Syndrome - therapy Humans Immunoglobulins, Intravenous - therapeutic use Infections Influenza Vaccines - administration & dosage Influenza Vaccines - adverse effects Internal Medicine Medical prognosis Muscle Weakness - complications Muscle Weakness - etiology Neural Conduction - immunology Neuropathology Paralysis - complications Paralysis - immunology Plasma Exchange Plasmapheresis Prognosis Respiratory Insufficiency - etiology Respiratory Insufficiency - prevention & control Treatment Outcome Vaccines
Title	Guillain-Barré syndrome
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S0140673616003391 https://www.clinicalkey.es/playcontent/1-s2.0-S0140673616003391 https://dx.doi.org/10.1016/S0140-6736(16)00339-1 https://www.ncbi.nlm.nih.gov/pubmed/26948435 https://www.proquest.com/docview/1814223225 https://www.proquest.com/docview/1812887321 https://www.proquest.com/docview/1815691391
Volume	388
WOSCitedRecordID	wos000381268700032&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250911 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M7P dateStart: 19920104 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Consumer Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250911 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0R dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1474-547X dateEnd: 20250911 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7X7 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database (ProQuest) customDbUrl: eissn: 1474-547X dateEnd: 20250911 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0T dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250911 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7RV dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1474-547X dateEnd: 20250911 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: BENPR dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 1474-547X dateEnd: 20250911 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2M dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database (ProQuest) customDbUrl: eissn: 1474-547X dateEnd: 20250911 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 8C1 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1474-547X dateEnd: 20250911 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2O dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250911 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2P dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoixAXyqt0oVSLxAEOpvEjtnNCbdXCZZeoFLQ3K3EcqRLKls0u_4nfwR9jxnHSy_Yh9TKSE39K5IxnvtjjGULea1MJJnxJZVp4KmufUFN7RTFvjEuTirOiCsUm9HRqZrMsjwtubQyr7G1iMNTV3OEa-QF4IgmuDNTv8-VvilWjcHc1ltDYIFvAbBiGdE14vu5cZAhxvzrBc_B9uPiBqY9Y0Syj7DrfdB33DD7odPu-b_-UPInsc3zYqcsz8sA3z8mjSdxff0F2v6ywCtFFQ4-KxeLf33Gf0OAl-XF6cn78lcbaCdSlhi9pIUrDPCuAlXJeAGmRAoueJ7WHX1JRcemNU4pn0E5qWWUGfLVzqi59KSvvvNghm8288btkXGpw8dprIesK_jbLMqwkZ6mpmeNMqBGR_ahZFxOLY32LX3ZNBBnDKDoYbMtG5NMAu-wya9wGUP0nsf2xUTB0Fmz_bUC9DujbOF1by2zLbdKhEcxUgALSDMjISDqmcZeH7vWaYK-eM6jBiLwbbsOExl2aovHzVejDwfILzm7skypM6Ap9XnUaOYwhHk02QIJf3_wCb8hj4H4Kl8eZ2COby8XKvyUP3Z_lRbvYJxv67CfKmQ7SgDTHbJ9sHZ1M8zNoTZJOnqPkkyC_BZmj1Pl_whgktA
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1JT9wwFH6iUJVeoDsDtJ1KrdQeXOIljnNAiC4UBIyQSiVubuI4EhLK0MlMq_4kLvwJ_hjvZeMyQC8cekziL7bst9l-C8DbyGSSS58yFSaeqdwHzOReM8ob48IgEzzJqmIT0WBgjo7igxk4b2NhyK2ylYmVoM6Gjs7I11ATKVRlSH4bp78YVY2i29W2hEZNFrv-7x_cspXrO19wfd8JsfX18PM2a6oKMBcaMWaJTA33PEF7TYgE1bmSVA48yD1u1mQmlDdOaxHjc5CrLDaoxZzTeepTlXnnJf73HswpyixGroLiYFocZuVSfxUxtPa9e_me6w9UQS1m_DpdeJ2tW-m8rcX_bbYewUJjXfc3a3Z4DDO-eAIP9hv_gaew9G1CVZaOC_YpGY0uzvptwoZn8ONOxvUcZoth4Zegn0ZowkQ-kirPcDedptVJeRyanDvBpe6BalfJuiZxOtXvOLFTPOQ4eQni4lreg48d7LTOHHIbQLckYNuwWBTkFnXbbcBoGtCXjTgqLbelsEGNJjDXFRSRpkM2FldtSf1Lp6st5dmrfjqy68Gb7jMKLLqFSgo_nFRtBGo2KfiNbUJNCWuxzYuaA7o5pNBrg0b-8s0DeA3z24f7e3ZvZ7C7Ag_RztV0FcDlKsyORxP_Eu673-PjcvSq4uE-_LxrNrgEEzR32g
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NT9RAFH9BNIQLigqsoqyJJnoYt_PR6fRgjIqLBNkQlYTb2E5fExLShe2uxj_Jf8Gr_5hv-sVlAS8cOLadX2cy875m5n0API9MJrnElKkwQaZyDJjJUTOfN8aFQSZ4klXFJqLRyBwdxQcL8KeNhfFula1MrAR1Nnb-jHxAmkiRKiPyG-SNW8TB9vDt6RnzFaT8TWtbTqMmkT389ZO2b-Wb3W1a6xdCDD9--_CJNRUGmAuNmLJEpoYjT8h2EyIh1a6kLw0e5EgbN5kJhcZpLWJ6DnKVxYY0mnM6TzFVGTqU9N9bcDtSofB5-_eDL_NiMiv3-vPoocHX7uVLrl_5amox4xfpxYvs3kr_De_e5Jm7ByuN1d1_V7PJKixgcR-W9hu_ggewsTPz1ZeOC_Y-mUz-_u63iRwewuG1jGsNFotxgRvQTyMybSKMpMoz2mWnaXWCHocm505wqXug2hWzrkmo7ut6nNg5nnPcew_SQlveg9cd7LTOKHIVQLfkYNtwWRLwlnTeVcBoHhDLRkyVlttS2KBGezDXFZSQpkM2llhtYf1Pp5stFdrzfjoS7MGz7jMJMn87lRQ4nlVtBGk8KfilbULtE9lSm_WaG7o59CHZhoz_R5cPYAuWiPrt593R3mNYJvNX-xsCLjdhcTqZ4RO4435Mj8vJ04qd-_D9urngHxC-gJ0
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Guillain-Barr%C3%A9+syndrome&rft.jtitle=The+Lancet+%28British+edition%29&rft.au=Willison%2C+Hugh+J%2C+Prof&rft.au=Jacobs%2C+Bart+C%2C+Prof&rft.au=van+Doorn%2C+Pieter+A%2C+Prof&rft.date=2016-08-13&rft.issn=0140-6736&rft.volume=388&rft.issue=10045&rft.spage=717&rft.epage=727&rft_id=info:doi/10.1016%2FS0140-6736%2816%2900339-1&rft.externalDBID=ECK1-s2.0-S0140673616003391&rft.externalDocID=1_s2_0_S0140673616003391
thumbnail_m	http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01406736%2FS0140673616X00347%2Fcov150h.gif